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„Die Diskussion darüber, welchen Anteil an der Entwicklung des Verhaltens von 
Tieren genetischen Ursprungs ist und welchen Anteil daran die Umwelt hat ist 
genauso hilfreich wie die Diskussion, welchen Anteil am Erklingen einer 
Klaviersonate der Pianist und welchen das Instrument hat. Das Klavier kann noch 
so gut gestimmt und noch so sorgfältig gezimmert sein, ohne die künstlerischen 
Fähigkeiten des Pianisten würde kein einziger Ton erklingen. Ebenso kann der 
Pianist noch so begabt sein, ohne ein Instrument, das ihm zur Entfaltung zur 
Verfügung steht, könnte auch er keine einzige Note zum Erklingen bringen. Nur 
das Zusammenspiel beider Seiten erlaubt uns den Genuss wunderschöner Musik. 
Genauso verhält es sich mit den Erbanlagen und der Umwelt. Die Gene stellen 
gewissermaßen die Klaviatur dar, auf der die Natur ihre Entfaltung findet. Nur im 
Zusammenspiel beider ergibt sich die Vielfalt der Organismen, die uns immer 
wieder staunend in Ehrfurcht versetzt.“ 
 
Konrad Lorenz (1903 – 1989), zitiert in “Das Verhalten von Hunden”, Heidenberger, E.,  
Augustus-Verlag München, 2000
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 SUMMARY  
Summary 
 
For quite some time the possible ability of chemicals to interfere with developmental 
processes in all kinds of organisms became a matter of concern. Their possible 
interaction with the endocrine system and therefore their potential to disrupt proper 
development makes chemicals a target of research since their global occurrence 
might put species at risk on a global scale. In fact the extinction of the European otter 
(Lutra lutra) in Switzerland is suspected to be due to the contamination of its major 
food source (fish) by endocrine disrupting chemicals (EDC), as stated in a 1999 
report released by the Swiss Agency for Environment, Forests and Landscape 
(BUWAL). Thus further research on the impact of potential EDC on developmental 
processes in mammals is an important issue. 
In early stages sex-hormones regulate the sexual development of an organism. 
Therefore ontogeny is a potential target for EDC. In mammals, sexual differentiation 
of the brain is driven by estradiol, which is derived from testosterone, catalyzed by 
the enzyme aromatase.  
Due to its structural similarity to the well known endocrine disrupters PCB 
(polychlorinated biphenyls) the brominated flame retardant PBDE99 
(pentabromodiphenyl ether congener 99) has been chosen to test its developmental 
toxicity in rats, with special emphasis on sexual development of the brain. To 
evaluate the results of PBDE99 and to assess the reproducibility of well known 
results with PCB under the conditions of this study an industrial PCB-mixture 
(Aroclor1254) has been chosen as positive control. 
In the current study, the possible effects on estrogen-regulated genes were analyzed 
by measuring mRNA levels in two sexually dimorphic brain regions, the medial 
preoptic area (MPO) and the ventromedial hypothalamus (VMH) of adult rat offspring, 
after developmental exposure to PBDE99. Therefore the test-compound was 
administered by subcutaneous injections to pregnant rats during sensitive phases of 
brain development in two doses of 1 and 10 mg/kg/day. Since the chemicals are 
lipophilic they accumulate in fat tissue and therefore exposure of offspring continues 
through pregnancy, lactation and adulthood. The study comprises two different 
experimental designs. First, the animals were exposed to PBDE99 until adulthood 
without any further treatment (baseline experiment). Then, to analyze the sensitivity 
to estradiol, another series of PBDE99-exposed offspring were gonadectomized at 
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the age of 10 weeks. After a recovery-period of two weeks, they were 
subcutaneously injected with one dose of estradiol and sacrificed six hours later to 
remove the brains (estrogen challenge).  
The respective brain regions were cut out from frozen brain slices. The mRNA 
encoding for estrogen receptor alpha (ER alpha), estrogen receptor beta (ER beta), 
progesterone receptor (PR) and preproenkephalin (PPE) were determined by Real-
time-PCR, using the standard curve method. Cyclophilin served as reference gene.  
The results of this study indicate that developmental exposure to PBDE99 affects 
mRNA expression of estrogen-regulated genes in adult rat offspring in a region- and 
sex specific manner. In the baseline experiment, treatment with PBDE99 leads to an 
abolishment of the original sex difference in PR mRNA levels in the VMH of untreated 
controls. Since PR mRNA level was found to be directly linked to female sexual 
behavior (Ogawa et al., 1994) treated females were tested with regard to this. Indeed 
a significant reduce in the performance of female sexual behavior could be detected 
in this study. In the acute estrogen challenge the effect of PBDE99 on the response 
to estrogen in gonadectomized adult offspring is gene dependent, and differs 
between sexes and brain regions. It turned out that the results obtained by treatment 
with the PCB-mixture Aroclor1254 differed from those obtained by treatment with the 
test compound PBDE99 in both parts of the study, in the baseline experiment and in 
the estrogen challenge. 
The present study reveals that developmental exposure to PBDE99, an endocrine 
active flame retardant, can affect sexual brain differentiation processes at the 
molecular level. The effects occurred at dosages that did not show any signs of 
general, non-specific toxicity. The alterations found may potentially interfere with the 
reproductive fitness of populations and are therefore a matter of concern as to the 
possible impact of the tested compounds on the environment. 
The analysis of gene expression represents a novel approach in research on 
hormonal effects of possible EDC on brain function. The results of this study reveal 
that hormone-regulated genes in the brain are a potential target of EDC. Hence, the 
molecular analysis provides a potent tool for the detection of these chemicals. 
 
2 
 ZUSAMMENFASSUNG  
Zusammenfassung 
Die Fähigkeit von Chemikalien in der Umwelt mit dem Hormonsystem sich 
entwickelnder Organismen zu interferieren gibt seit geraumer Zeit Anlass zur Sorge. 
Ihr möglicher Eingriff in das Hormonsystem und daher ihr Potential die Entwicklung 
von Organismen zu stören lässt sie von zunehmendem Interesse für die Forschung 
werden. Ihr weltweites Vorkommen könnte zu einem globalen Risiko für das 
Überleben von Arten werden. Tatsächlich wird das Aussterben des Europäischen 
Fischotters (Lutra lutra) in der Schweiz in einem Bericht des Bundesamtes für 
Umwelt, Wald und Landschaft (BUWAL) von 1999 in Verbindung gebracht mit der 
Kontamination seiner Hauptnahrungsquelle (Fisch) mit hormonaktiven Chemikalien 
(endocrine disrupting chemicals = EDC). Daher ist die Forschung über den Einfluss 
von EDC auf Entwicklungsprozesse bei Säugetieren ein wichtiges Anliegen.  
In frühen Entwicklungsstadien regulieren Sexualhormone die sexuelle 
Entwicklung eines Organismus. Deshalb ist die Ontogenie ein mögliches Ziel für den 
Eingriff von EDC in diesen Prozess. Bei Säugetieren wird die sexuelle 
Differenzierung des Gehirns durch Estradiol gefördert. Dieses wird durch das Enzym 
Aromatase aus Testosteron gebildet.  
Wegen seiner ähnlichen chemischen Struktur mit den bekannten hormonaktiven 
PCBs (Polychlorierte Biphenyle) wurde das bromierte Flammschutzmittel PBDE99 
(Polybromierter Diphenylether Kongener 99) ausgewählt, um es auf seine potentielle 
Entwicklungstoxizität in Ratten zu testen. Dabei lag der Schwerpunkt auf der 
sexuellen Differenzierung des Gehirns. Um sowohl die Ergebnisse von PBDE99 als 
auch die Vergeichbarkeit mit wohlbekannten Resultaten bei PCBs unter den 
Bedingungen dieser Studie bewerten zu können, wurde eine industrielle PCB-
Mischung (Aroclor1254) als Positivkontrolle ausgewählt. 
In der vorliegenden Studie wurden die möglichen Auswirkungen auf 
estrogenregulierte Gene analysiert durch die Messung von mRNA-Mengen in zwei 
sexuell dimorphen Gehirnregionen, der medialen präoptischen Region (MPO) und 
dem ventromedialen Hypothalamus (VMH) nach Exposition durch PBDE99 während 
der Entwicklung. Dafür wurde die Testchemikalie in zwei Dosen (1 bzw. 10 
mg/kg/Tag) trächtigen Ratten während sensibler Phasen in der Entwicklung des 
Gehirns durch subkutane Injektionen verabreicht. Wegen ihrer lipophilen 
Eigenschaften akkumulieren sie im Fettgewebe, und daher dauert die Exposition fort 
von der Trächtigkeit über die Säugephase bis in die Adultzeit. Die Studie umfasst 
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zwei unterschiedliche experimentelle Teile. Im ersten Teil wurden die Tiere lediglich 
mit PBDE99 behandelt ohne weitere Manipulation (baseline). Im zweiten Teil wurden, 
um die Sensitivität gegenüber Estradiol zu testen, 10 Wochen alte PBDE99-
behandelte Junge im Alter von 10 Wochen gonadektomiert. Nach einer 
Erholungsphase von zwei Wochen, bekamen sie ein s.c. Behandlung mit einer Dosis 
Estradiol. Sechs Stunden später wurden sie getötet und die Gehirne entnommen 
(estrogen challange).  
Die jeweiligen Gehirnregionen wurden aus gefrorenen Gehirnschnitten 
herausgestanzt. Die mRNA, die für die Gene Estrogenrezeptor alpha, 
Estrogenrezeptor beta, Progesteronrezeptor und Preproenkephalin kodieren, wurden 
mittels realtime-PCR bestimmt. Dabei wurde die Standardkurvenmethode angewandt 
und Cyclophillin als Referenzgen genutzt.  
Die Ergebnisse dieser Studie deuten darauf hin, dass die Behandlung mit PBDE99 
während der Entwicklung die Expression von mRNA estrogenregulierter Gene 
verändert. Dies geschieht in regionen- und geschlecht-spezifischer Weise. Im 
baseline-Experiment verschwand der Unterschied im PR-mRNA-level zwischen 
Weibchen und Männchen, der bei unbehandelten Kontrollen sichtbar wurde. Da 
Ogawa et al., 1994 gezeigt haben, dass die mRNA-Menge an PR im VMH direkt in 
Verbindung gebracht werden kann mit dem Rückgang von weiblichem 
Sexualverhalten, wurden die behandelten Weibchen untersucht im Hinblick darauf. 
Und tatsächlich wurde in dieser Studie ein signifikanter Rückgang in der 
Zurschaustellung weiblichen Sexualverhaltens beobachtet. Im Akutstudien-Teil war 
der Effekt der Behandlung adulter gonadektomierter Nachkommen mit PBDE99 auf 
die Antwort auf Estrogene genabhängig und variierte zwischen den Geschlechtern 
und den verschiedenen Gehirnregionen. Es stellte sich heraus, dass in beiden Teilen 
der Studie (sowohl im baseline-Experiment, als auch im Akutversuch) der Einfluss 
von PBDE99 sich von dem der PCB-Mischung deutlich unterschied.  
Mit der vorliegenden Studie konnte gezeigt werden, dass die Exposition gegenüber 
dem hormonaktiven Flammschutzmittel PBDE99 während der Entwicklung die 
sexuelle Differenzierung auf molekularer Ebene beeinflussen kann. Die Effekte traten 
bei Dosierungen auf, die keine Zeichen allgemeiner, unspezifischer Toxizität zur 
Folge hatten. Die beobachteten Veränderungen sind möglicherweise geeignet, die 
biologische Fitness von Organismen zu beeinträchtigen und geben deshalb Anlass 
zur Sorge im Hinblick auf den Einfluss der getesteten Substanzen auf die Umwelt.  
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Die Analyse von Genexpressionsdaten stellt einen neuen Ansatz zur Untersuchung 
hormoneller Wirkungen möglicher EDC auf die Funktion des Gehirns dar. Die 
Ergebnisse dieser Studie zeigen, dass hormonregulierte Gene im Gehirn einen 
möglichen Angriffspunkt für die Wirkung von EDC sein können. Dadurch bietet die 
molekulare Analyse ein geeignetes Werkzeug für die Aufdeckung der hormonellen 
Wirkung dieser Chemikalien.  
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INTRODUCTION 
Development and environment 
The reciprocal impact of environment vs. genetics on the development of organisms 
is a matter of long-lasting debates. It will not be solved finally in this study as well, but 
the results of this study will clearly show, that the chemically contaminated 
environment on our planet may have a severe influence on mammalian development. 
The following introduction serves to give an overview on the state of the art in sexual 
development in mammals and from there it will become clear how endocrine 
disrupting chemicals interfere with this process. 
 
Sexual development in mammals 
 
Determination of sex 
In birds and mammals, the sexual phenotype depends on the combination of 
heterosomes, like X and Y in mammals: XX means female, XY male. The presence 
of a Y chromosome determines the differentiation of the bipotential mammalian 
gonads into testes. Within this differentiation process the SRY gene (sex determining 
region on the Y chromosome) plays a crucial part. Once SRY is activated the 
developmental pathway to testis formation is initiated. The whole complicated 
process involves a set of genes, among them SF1 (steroidogenic factor 1), which 
initialises the synthesis of testosterone in the Leydig cells as well as the secretion of 
the anti Mullerian hormone (AMH) in the Sertoli cells. This secretion in turn leads to 
the regression of the Mullerian duct and to the formation of the epidydimis, seminal 
vesicles and the vas deferens.  
Testosterone is the differentiation signal for the inner male genital organs. In the 
prostate, a urogenital sinus derivative, testosterone is converted into 5α-dihydrotesto-
sterone (DHT), which shows higher affinity to androgen receptors. Furthermore, 
testosterone is converted into estradiol by the enzyme aromatase. Since prostate 
development depends on a combination of androgenic and estrogenic actions, both 
hormones are necessary for proper urogenital development.  
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Fig. 1: Aromatase action to convert testosterone to estradiol or 5α-reductase action to 
convert it to dihydrotestosterone 
If the organism carries two X-chromosomes, the gonadal development takes the 
female route, forming the ovaries. DAX1, a gene on the X chromosome, is expressed 
in the same cells as SRY and suppresses SF1 expression. The autosomal gene 
WNT4, expressed in XX gonads, determines ovary development. Under its influence 
the mesenchym cells of the ovary differentiate into the thecal cells. Together thecal 
and granulosa cells form the follicles, which secrete steroid hormones. The inhibition 
of SF1 by DAX1 in turn inhibits the expression of AMH leading to persistence of the 
Mullerian duct, which then differentiates into the oviducts, uterus, cervix and upper 
vagina. The Wolffian duct degenerates (Gilbert 2000).  
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Fig. 2: Sexual differentiation of the bipotential gonad 
 
Interference of endocrine disrupting chemicals (EDC) 
If the organism is exposed to endocrine disrupting chemicals (EDC) during this 
critical period of sex differentiation, this can lead to severe defects like morphological 
pseudohermaphrodism, which means that the genetic information is reversed in the 
phenotype, leading to XY-females and XX-males (Schardein 1993). However, EDC 
do not only generate morphological changes, physiological and behavioral aspects 
are affected as well (Gray, 1992). 
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Sexual differentiation of the rat brain 
The sexual differentiation of the mammalian brain takes place under the control of 
gonadal steroid hormones. Action of these hormones during a restricted 
developmental time period results in permanent changes of hormonal sensitivity of 
sexually dimorphic regions of the adult brain. Similar to periphery, the developing 
nervous system of either sex originally is bipotential. Depending on early hormonal 
influence, the CNS undergoes either feminisation or masculinisation. 
Beginning at gestational day (GD) 13 the Leydig cells of the rat testes synthesize 
androgens; testosterone plasma level reaches a peak at GD 18 (Weirz and Ward, 
1980). Via bloodstream testosterone is transported to the brain. Masculinisation 
processes are initialised in the brain at gestational day 18 and continue during the 
early postnatal period until approximately the end of the first postnatal week. In nerve 
cells of special brain regions, such as the medial preoptic area (MPO) and the 
ventromedial hypothalamus (VMH), the enzyme aromatase transforms testosterone 
into estradiol, which binds to estrogen receptors (Pilgrim & Hutchison 1994; Lauber & 
Lichtensteiger, 1994). The peak of estradiol in the brain during this particular time 
window causes masculinisation and represses feminisation. The activation of 
estrogen receptors by estradiol regulates gene expression, which in turn influences 
differentiation processes in neurons, that later result in the establishment of male 
behavior (masculinisation) and suppression of female behavior and female estrous 
cycle (defeminisation). The original brain pattern in mammals is female and in order 
to achieve a male pattern, it has to be masculinised (Gorski, 1971). Male rats 
castrated between one and five days of age develop behavioral characteristics of 
genetic females, and if they are injected with estrogen and progesterone as adults, 
they display female sexual behavior. The influence of steroid hormones on the 
developing CNS determines not only sexual behavior and gonadotropin release but 
also many other functions, such as learning behavior and activity patterns, as well as 
taste preferences and circadian rhythms (Steward, 1975; Valenstein, 1967; Gerall, 
1976).  
Detailed molecular mechanisms of sexual differentiation in the brain still remain 
unclear. The study of sexually dimorphic brain regions, as intended in this study, 
might help to better understand the underlying mechanisms in the development of 
the brain. 
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Most features of sexually dimorphic brain functions can be linked to the action of sex 
hormones during a critical period of brain development. However, it should be noted 
that there is evidence for an additional direct genetic control of sex differences in 
certain neuron groups (Sibug et al., 1996, Reisert et al., 1996 and 2002), but also 
growth and differentiation of such neurons is under control of estrogen (Kuppers et 
al., 2000). Since (developmental) actions of hormones represent the primary target of 
endocrine disrupters, we focus on these processes.  
Neuron
Male Brain Differentiation
Fetal
Testis
Masculinization:
Expression of male behavior patterns
Defeminization:
Suppression of female behavior 
patterns and acyclic gonadal
regulation
Neuron
circulating
Testosterone
Protein Synthesis m-RNA
EREstradiol
Aromatase DNA
 
Fig. 3:  Action of testosterone on neurons in the central nervous system of rats. 
Testosterone is synthesized by the fetal testis and is transported via the bloodstream into the 
brain. In the neurons, the enzyme aromatase converts testosterone into estradiol, which 
binds to estrogen receptors and acts on the DNA, inducing transcription or repression of 
target genes. This leads to the sexual brain differentiation, masculinisation and a 
defeminisation (Fig. taken from Schlumpf & Lichtensteiger, 1996). 
Anatomy of the central nervous system of the rat 
The characteristic shape of the rat brain (Fig. 4) consists of the two prominent 
olfactory bulbs, the pear shaped forebrain and the two cerebral hemispheres, which 
are divided by a deep longitudinal fissure (fissura longitudinalis cerebri). Caudally the 
cerebrum is separated from the cerebellum by a deep transverse fissure (tentorium 
cerebelli). 
In Fig. 4 the dorsal view (A) shows the olfactory bulbs followed caudally by the 
olfactory tracts (tractus olfactorius). The ventral view (B) exhibits in the midline the 
10 
 INTRODUCTION    
optic chiasma (chiasma opticum). Caudally to the optic chiasma is, attached to the 
base of the brain, the pituitary gland (hypophysis). The medulla oblongata is 
projecting down the spinal cord. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) 
(A) 
Medulla oblongata 
Hypophysis 
Tractus olfactorius 
Chiasma opticum 
Corpus pineale 
Cerebellum 
Cerebrum 
Olfactory bulb 
Fig. 4: Dorsal (A) and ventral (B) view of the rat brain (magnification 1.2x) 
 
 
Sexually dimorphic brain regions 
The mammalian brain regionally shows sexual dimorphism. This is reflected by 
morphological and neurochemical differences between the two sexes, established via 
exposure to sex steroid hormones during the perinatal period. This study mainly 
focuses on two brain regions, the ventromedial hypothalamus (VMH) and the medial 
preoptic area (MPO), which are involved in the control of reproductive behavior and 
gonadal functions, both in males and females. They are known to be driven by 
estrogens. 
 
Medial Preoptic area (MPO) 
Located at the level of the junction of diencephalon and telencephalon, the medial 
preoptic area (MPO) is lying ventral to the anterior commissure, close to the 
hypothalamus (Riley, 1960) (Fig. 5). Anatomically and functionally it connects the 
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limbic centres with the vegetative hypothalamus. The MPO exhibits a high density of 
colocalized progesterone-and estrogen receptors (Gorski, 1980). The MPO contains 
a cell-dense region called the sexually dimorphic nucleus of the medial preoptic area 
(SDN-POA), which shows sexual dimorphism with regard to the size of certain cell 
clusters, or the distribution of certain transmitter systems. It is double to five times 
larger in males than in females. Although its function still remains unclear, it is 
assumed, that the enhancement of neurogenesis in this region via testosterone 
action may play a role in masculinisation processes (George 1982). The increased 
volume of the SDN in males is thought to be induced by estradiol, generated from 
testosterone, as the expression of the transforming enzyme, aromatase, differs in the 
SDN of both sexes (Lauber et al., 1997). Research on potential endocrine disruptors 
has used the volume of SDN-POA as a parameter in female rodents. While the 
endocrine disruptor bisphenol A had little effect on SDN-POA volume of treated 
rodents (Nagao et al., 1999), neonatal exposure to diethylstilbestrol (DES) (Faber et 
al., 1993) and genistein (Faber & Hughes 1991, 1993) increased the SDN-POA 
volume of genetic females.  
The MPO neurons contain more estrogen receptors than any other brain region of 
both sexes, males and females (Herbison, 1992). The MPO is found to be involved in 
the regulation of reproductive behaviour (Sodersten, 1985). In males, the MPO is 
important for copulatory behaviour, whereas in females it is involved in the regulation 
of maternal behaviour, lordosis and estrous cycle. In males as well as in females 
electrophysiological activities within the MPO increase during mounting (Kartha, 
1996) and lesions at this site enhance lordosis behaviour in females (Powers & 
Valenstein, 1972) or are hamstring copulatory behavior in males (Klaric, 1985).  
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Fig. 5:  Schematic figure of the medial preoptic area (MPO), bilateral on the right and 
left side of the third ventricle (3V). The MPO contains the sexual dimorphic 
nucleus (SDN).  
 
Ventromedial hypothalamus (VMH) 
Ventral to the diencephalon and dorsal to the anterior hypothalamic area, the 
ventromedial hypothalamic nucleus (VMH) is located (Fig. 6). Like the MPO the VMH 
is sexually dimorphic in structure and function and it is an important target for 
regulating action of steroid hormones. Despite the overall volume of the VMH is being 
larger in males, in females the VMH neurons were found to be larger and to express 
higher ER alpha levels than in males. The distribution of ER beta, however, does not 
differ between the sexes, which may also be due to its very low expression level in 
this region (Ikeda et al, 2003). In behavioural experiments lesions of the VHM 
disrupted copulatory behavior in female rats (Kennedy, 1964). 
The difference in size of the VMH between males and females seems to depend on 
the estrous cycle; the sexual dimorphism is more clear-cut when female rats are in 
diestrus (Madeira et al., 2001). The VMH mediates the lordosis behavior in females 
via modulation of ER and PR (Pfaff, 1980). 
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Fig. 6: Schematic figure of the ventromedial hypothalamus (VMH), which is located on 
both sides of the third ventricle (3V), Arc = Nucleus arcuatus 
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Fig. 7: Frontal brain slides with MPO (A) and VMH (B) (4,84x) 1: Corpus; 2: Commissura anterior;
3: nucleus caudatus putamen; 4: Radiatio corporis callosi;  5: capsula interna; 6: fimbria hippocampi;
7: tractus opticus 
 
 
 
 
 
 
 
 
 
 
 
 
 
Male sexual behavior 
Sexual behavior of male rats mainly comprises three behaviors: Mounting 
(assuming the copulatory position from behind and on the back of the female), 
intromission (penis is put into the female’s vagina) and ejaculation (determined as 
forceful expulsion of semen). Depending on the female’s reaction the male exhibits 
all three parts of this copulatory behavior or it breaks off before finishing the whole 
process. Usually, the male only ejaculates, if the female exhibits lordosis behavior. A 
successful complete mating can be recognized by the fact that the male licks his 
genitals. Typically rats have multiple ejaculations. In average ejaculation only follows 
after a number of mounts and intromissions. Multiple measures of the ratio between 
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mounts, intromissions and ejaculations are used to evaluate sexual motivation and 
performance. 
 
Female sexual behavior 
Female reproductive behavior comprises proceptive (female initiated) as well as 
receptive (response to the male) behavioral components. In order to display mating 
behavior a female rat must be sexually receptive (Bradling-Bennet, 1999). The 
mammalian female formerly was considered as a 'passive recipient' in copulation. 
Female sexual behavior was measured exclusively in terms of the “lordosis quotient”. 
Lordosis is a characteristic posture in which the female rodent arches her back to 
allow the male the copulation act. But recent studies (Erskine, 1989) have shown that 
this rather passive receptive behavior is only one part of female reproductive 
behavior. The female rat is also initiating copulation, thus playing a much more active 
role. In order to attract the male, the female approaches him actively with behaviors 
such as wiggling ears, hopping and darting in front of her partner. The female even 
influences the number and timing of copulations by approaching the male and 
withdrawing from him, provided that enough space is available. This entire and rather 
complex behavioral pattern is referred to as paced mating behavior. 
It has been shown that sexual behavior of the female is regulated by steroid 
hormones in specific brain regions, such as the VMH (Rajendren, 1991). For example 
lesions can totally suppress the estrogen-induced lordosis reflex. The most influential 
regulating hormones for paced mating behavior are estrogens (estradiol) and 
progesterone. The display of receptive behaviors like lordosis depends on the 
sequential action of estrogen followed by progesterone. It can be blocked by 
intracerebral injection of antisense oligonucleotides against Progesterone receptor 
(PR) mRNA. (Ogawa et al, 1994). Under certain experimental conditions, lordosis 
reaction can also be facilitated by estrogen alone (Fadem, 1979; Gilman & Hitt 1978). 
Progesterone also regulates proceptive behavior.  
It turns out that the receptive as well as the proceptive behavior components are 
subject to independent regulation mechanisms in the CNS. This has been proven in 
studies, where perceptive (lordosis) behavior in ovarectomized hormone-primed 
females did not show any difference from intact females, whereas proceptive 
behaviors have been altered in the treated as compared to the control animals 
(Zipse, 2000). 
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Females with a mutation of the progesterone receptor are not able to display 
soliciting behavior and lordosis (Motoyasu 1996). As mentioned above, if antisense 
oligonucleotides for PR mRNA are injected into the VMH progesterone-facilitated 
female sexual behavior is being suppressed (Ogawa et al., 1994). The involvement of 
the MPO in female sexual behavior seems less clear, since application of estrogen 
as well as lesions of the MPO can increase lordosis responses. Taken together, 
estrogen shows inhibiting as well as stimulating effects on lordosis and regulates in 
association with progesterone sexual behavior in females. 
 
Steroid Hormones 
Steroid hormones consist of multiple carbon-ring-structures and are generated 
from cholesterol in the ovary and testis. They are regulated by a feedback-
mechanism via the hypothalamus-pituitary-gonad axis (Fig. 10) and regulate a wide 
variety of cellular mechanisms, like cellular differentiation, cell migration or cell death. 
For instance in male brain, steroids are responsible for masculinisation processes 
and initiate neurogenesis and synapse formation. 
Estrogens 
Estrogens have originally been referred to as the female hormones. They are derived 
from androgens and in blood are found in relatively higher levels in females as 
compared to males. There are three different natural estrogens: 17β-estradiol, estriol 
and estron (Fig. 8). Among them the most potent estrogen is 17β-estradiol (E2), it is 
produced in the follicle’s epithelial cells. In ovaries and, to lower extents in testes, 
estrogens are produced by de novo synthesis. Additionally estrogens are derived via 
conversion of androgens by the enzyme aromatase in a wide variety of organs such 
as brain and fat tissue in both sexes. Estrogens play a major role in the control of 
both female and male reproduction. They regulate the female menstrual cycle, have 
an impact on growth and behavior, and affect brain development. Furthermore they 
regulate morphological, biochemical and electrophysiological matters in numerous 
brain structures, such as memory, emotions, motor coordination and pain sensitivity 
(Hampson, 1990, Sherwin, 1998). A small part of estradiol is freely available in the 
blood, but most of it is bound to a transport protein called the sex-hormone-binding 
globulin (SHBG). 
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Fig. 8: The three natural estrogens: 17β-estradiol, estron and estriol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gestagens 
The gestagens are a second group of steroid hormones. The gestagen progesterone 
is involved in the maintenance of pregnancy and the differentiation of the 
endometrium and the mammary gland and is synthesized in the theca and stroma 
cells of the ovary during the luteal phase of the estrous cycle. Progesterone is 
synthesized at several sites such as the adrenal cortex, the corpus luteum, the 
placenta and the testes. In blood, progesterone is mostly bound to corticosteroid-
binding globulin (CBG) or to sex-hormone-binding globulin (SHBG) and to albumin. In 
rodents the regulating actions of progesterone in the central nervous system (CNS) 
have been found to be sexually dimorphic (Blaustein et al. 1980; Samama & Aron 
1991). It is responsible for proceptive, sexual and maternal behavior. In specific 
regions of the CNS progesterone receptors (PR) are often associated with estrogen 
receptors. The PR gene contains a number of estrogen responsive elements (ERE’s) 
in the promoter region (Kraus et al., 1993). Progesterone together with estrogens 
regulates functions of female reproductive behavior including the induction of 
lordosis. Furthermore it controls the induction of ovulation. In males, it is found to play 
a role in the control and mediation of sexual behavior as well (Phelps et al. 1998). 
Progesterone mRNA expression in brain regions is directly regulated by estradiol 
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(Shughrue, 1997). It has been hypothesized that a possible mechanism of the brain’s 
estrogen-driven masculinisation during ontogeny is being controlled by progesterone 
expression in nerve cells (Quadros, 2002). 
Androgens 
The main site for the synthesis of the most important androgen, testosterone, are the 
Leydig cells in the testis. Here cholesterol is transformed into testosterone via the 
intermediates progesterone and androstendione. Androstendione, secreted by the 
adrenal gland, serves as a further source of androgens. In a variety of male sexual 
organs like prostate, seminal vesicles and penis, testosterone is transformed by the 
enzyme 5α-reductase into 5α-dihydrotestosterone (DHT) (Fig. 9). DHT possesses a 
higher affinity for the androgen receptor. It regulates the differentiation processes in 
tissues where it is converted from testosterone. 
 
 
 
 
 
 
 
 
 
O
Testosterone
O
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H
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Fig. 9: Transformation of testostreone into 5α-dihydrotestosterone 
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Fig. 10: This figure represents the sex hormone regulation in mammals. Gonadotropin 
releasing hormone (GnRH) from the hypothalamus stimulates the pituitary, 
which leads to secretion of follicle stimulating hormone (FSH) and luteinizing 
hormone (LH). These two gonadotropins stimulate the gonadal activity. In the 
male (m) testis, testosterone and inhibin is produced, which regulates secretion 
of GnRH, LH and FSH from the hypothalamus and pituitary via a feed-back 
mechanism. In female (f) ovaries secretion of estradiol, progesterone and 
inhibin is stimulated by FSH and LH. Estrogen stimulates or inhibits 
hypothalamus and pituitary in females and exerts only a negative feed-back in 
males. Inhibin inhibits FSH and LH synthesis. Progesterone exerts positive or 
negative influences on the hypothalamus. At brain level, feedback effects of 
testosterone are mainly mediated by estradiol locally generated from 
testosterone, but there also exist androgen-mediated effects. 
Estrogen-regulated genes 
Steroid hormone receptors 
Sex steroid hormones regulate the transcription of selected genes via docking to 
specific receptors, located either in the cytosol or the cell nucleus. Nuclear steroid 
hormone receptors all have three main domains: The estrogen receptor (ER) is the 
main mediator of estrogen- regulated gene expression. It is part of the steroid 
hormone receptor superfamily of nuclear receptors. The estrogen receptor has a 
typical structure (Fig. 11). The centre of the amino acid chain contains the DNA 
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binding domain with a zinc finger- structure. The N-terminal end and the carboxyl- 
end (CE) of the chain contain transactivation domains (AF1 and AF2) and a ligand-
binding domain (LBD), respectively.  
 
 
N-terminal            DNA-binding         ligand-binding (LBD)               CE   
(AF1)           domain (DBD)       and activation domain (AF2) 
 
 
 
 
Fig. 11: Schematic structure of nuclear receptors and their domains 
When estrogen binds to the ER, a conformational change causes the dissociation 
from heat shock proteins (hsp90), and leads to receptor dimerisation. The receptor 
homodimer then binds to specific hormone receptor palindrome elements (HRE) of 
the steroid-responsive target gene, estrogen response element (ERE) in the case of 
estrogen. Nuclear receptor coregulators (coactivators, corepressors) are recruited. 
Coactivators facilitate local disintegration of nucleosomes by acetylation of histones, 
and are also involved in transactivation, interacting with the transcription factor 
complex (TF), which finally leads to activation of RNA polymerase II. 
Target cell
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 Fig. 12: Molecular mechanisms of steroid hormones (estradiol, red asterisks) or EDC (green arrows) 
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Estrogen receptors, ERα and ERβ 
There are two subtypes of estrogen receptors, ERα and ERβ. Their difference is in 
the C-terminal ligand-binding domain as well as in the N-terminal activation domain 
and they are differently distributed among target tissues. ERα has a higher level of 
expression in uterus, testis, pituitary, ovary, kidney and epididymis, whereas a slightly 
higher ERβ expression level was found in prostate, ovary, lung, bladder and uterus. 
Since the distribution of the two estrogen receptors in part is overlapping they may 
also work together as agonistic components (Barkheim et al, 1998). Yet, the exact 
roles of the two types of ER claims for further research. 
In the brain their distribution pattern is heterogeneous as well. In the ventromedial 
hypothalamus (VMH) and the arcuate hypothalamic nucleus only ER alpha signals 
were detected by immunohistochemistry (Ikeda et. al., 2003, Shughrue et al.; 1997, 
2001, Pelletier et al., 1988), whereas in the medial preoptic area (MPO), the bed 
nucleus of the stria terminalis, the cortical nuclei of the amygdala and other regions 
both, ER alpha and ER beta, have been found. In a number of brain regions ER beta 
represents the main ER. 
Corpus callosum
Hippocampus
Midbrain
Olfactory bulb
Septum
Preoptic area Hypothalamus
Pituitary
 
Fig. 13: The different sites of estrogene receptors in the brain 
A knockout study has shown that ER alpha in the brain plays some role in 
reproductive matters (Couse & Korach, 1999). One of ERα’s many functions is the 
control of female sexual behavior and reproduction. ERα knock-out mice revealed a 
decreased lordosis response and reduced level of parental behavior (Ogawa, 1998). 
ER beta knockout mice revealed a role of this ER type in brain development (Wang 
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et al., 2001, 2003). Together with ER alpha, ER beta is involved in sexual brain 
differentiation and in the control of sexual behavior (Kudwa et al., 2003, 2005).  
Progesterone receptor 
The progesterone receptor (PR) also is involved in the regulation of reproductive 
matters. Progesterone receptors play a major role in the induction of lordosis 
behavior and in the control of luteinising hormone secretion. Induced by estrogens, 
PR is found in numerous brain regions. Its mRNA expression level is relatively high in 
the medial preoptic area (MPO) as well as in the ventromedial hypothalamus (VMH) 
(Hagihara et al., 1992). A remarkable sexual dimorphism was found in the 
ventrolateral part of the ventromedial hypothalamic nucleus (VMN) in terms of the 
gene regulation of PR (Brown et al., 1987; Lauber et al., 1991). Progesterone 
Receptor appears to be significantly more sensitive to estradiol in female VMN as 
compared to the male one, since low doses of estradiol increased PR mRNA 
expression in the VMN only in females (Lauber et al., 1991). In the preoptic regions, 
however PR expression reacted equally to estradiol application in both sexes (Brown 
et al., 1987). 
Preproenkephalin 
Preproenkephalin serves as precursor of the neuropeptide met-enkephalin (Noda et 
al. 1982; Akil et al., 1984). Preproenkephalin mRNA can be found in many regions of 
the rat brain, comparatively high expression levels are detected in striatum, olfactory 
tubercle, amygdala and VMH. The PPE gene promoter has two estrogen response 
elements (ERE) and prolonged application of estrogens raise the PPE mRNA levels 
in the hypothalamus (Zhu et al., 2001). PPE in the hypothalamus and limbic system is 
involved in the control of reproductive behaviors such as lordosis (Micevych et al., 
1992, Lauber et al., 1990). The regulation of preproenkephalin (PPE) mRNA level in 
the VMN by estradiol is sexually dimorphic. In ovarectomized rats with average 
estrogen sensitivity PPE mRNA increased, whereas in orchidectomized males there 
was no response, neither to estradiol nor to testosterone (Roman et al., 1990). 
Endocrine-disrupting chemicals 
As stated above, steroid hormone receptors are controlling crucial events in 
embryonic development and sexual differentiation via their function as ligand-
inducible transcription factors. They either activate or repress the transcription of 
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target genes. The consequences of disrupting these crucial processes can have 
especially severe consequences if they occur in sensitive periods during 
development. Additional interactions of xenobiotics are possible at the level of steroid 
hormone synthesis (e. g., aromatase), metabolism, and transport. The delicately 
balanced regulatory mechanisms are in danger of being seriously altered, resulting in 
abnormal differentiation of reproductive organs and central nervous system. In adult 
age, when hormones have no longer an organizing but an activating or inhibiting 
function, exposure to EDC may lead to diminished reproductive success and it may 
harm the fitness of the affected organism. Although first studies on synthetic 
chemicals and their estrogenic actions have been carried out back in the 1920’s 
(Allen and Doisy, 1923), it is in the 1960´s when the population decline of different 
bird species in several regions of the United States increased the awareness of these 
environmentally relevant chemicals. During the past decades there has been an 
increasingly controversial debate among scientists and the public in terms of possible 
adverse effects of different chemical compounds found in the environment, 
suspected to interfere with the regular functioning of the endocrine system. These 
chemicals therefore have been named “Endocrine-disrupting chemicals (EDC)”. At 
the European workshop on the impact of endocrine disruptors in Weybridge back in 
1996 the two following definitions for “endocrine disrupting chemicals” were 
established: 
“An endocrine disruptor is an exogenous substance or mixture that alters function(s) of the 
endocrine system and consequently causes adverse health effects in an intact organism, or its 
progeny, or (sub) population.” 
 
“A potential endocrine disruptor is an exogenous substance or mixture that possesses 
properties that might be expected to lead to endocrine disruption in an intact organism, or its 
progeny, or (sub) population.” 
 
EDC are either of natural origin or generated in industrial production processes. The 
list of synthetic chemicals is growing exponentially and so is evidence of their 
increasing occurrence in the environment. The majority of EDC so far identified is 
lipophilic and have the capacity to bioaccumulate. Because they have hormone-like 
properties, a large number of these persistent compounds are likely to interfere with 
physiological pathways in all kinds of organisms. 
It therefore is not surprising that several field and laboratory studies have revealed a 
number of chemicals as contributors to adverse effects in wildlife species and 
populations. For instance, polychlorinated biphenyls (PCB) have been shown to exert 
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adverse effects on the reproduction of seals (Phoca vitulina) in the Northsea 
(Germany), leading to a marked decrease of population size (Reijnders 1986).In the 
middle of the 1980s, anglers in Great Britain reported to have caught fish (Rutilus 
rutilus) with both male and female characteristics. They were found in river waters 
downstream to sewage outflows. The hermaphroditic characteristics of these fish 
were hypothesized to originate from the increased release of contraceptives (Purdom 
et al. 1994). In some regions, the levels of vitellogenin, which normally is only 
synthesized in the liver of females, reached levels in male fish similar to those of 
female fish taken from uncontaminated waters. Reijnders and Brasseur reported in 
1992 the occurrence of female marine snails (Nucella lapillus) carrying male 
genitalia, including penis and vas deferens. Exposure to the marine antifouling paint 
tributytltin (TBT) was found to be responsible for these disturbances. 
In addition to these findings in wildlife of aquatic ecosystems, harmful effects have 
also been revealed in terrestrial species. For instance, 90% of the male population of 
Florida panthers (Felis concolor), shows cryptorchidism. And sperm abnormalities in 
this population exhibit the highest rate ever found in felines (Facemire 1995). Another 
frequently characteristic example is eggshell thinning and altered gonadal 
development, the feminisation of male embryos and breeding behaviour 
abnormalities in birds feeding on insects which were exposed to DDT. (Anderson and 
Hickey, 1970; Spitzer et al., 1978). Public attention to this entire problem was first 
raised by Rachel Carson's book “The silent spring”, back in 1962, in which she 
described fictively the future consequences of bird’s exposure to DDT: extinction of 
songbirds – a silent spring. It seems conceivable that exposure to environmental 
endocrine disruptors may account for a large part of widely observed reproductive 
abnormalities (Facemire 1995). 
Besides these reports on the disruption of normal endocrine functions in the fauna of 
various ecosystems, there is increasing evidence for possible harmful effects on 
human health. Quite well known end points of suspected effects of EDC are, for 
example, testicular and prostate cancers in men, reduced male fertility, breast cancer 
and endometriosis in women, abnormal sexual development, immune suppression, 
alteration in pituitary and thyroid gland functions and effects on neurobehavioral 
functions (Crisp et al. 1998). 
Nowadays there is a growing number of members of various chemical groups which 
are suspected EDC, amongst them pesticides, industrial chemicals, and 
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phytoestrogens. Endocrine disruptors which act in a similar way as the natural 
estrogens, such as e. g., 17β-estradiol, and therefore are called xenoestrogens 
(Sonnenschein & Soto 1998), do not necessarily share structural similarities with the 
natural estrogens. Nevertheless they are capable of evoking agonistic or antagonistic 
responses in estrogen receptors (Zacharewski 1997). 
The first compounds identified as EDC were organochlorines like DDT, PCB’s, and 
Dioxins. Most of them are nowadays prohibited in Europe and North America but 
many of them are still in use in South America, Africa and Asia. Possibly more 
important in the future are modern technical products with EDC properties such as 
surface active chemicals (alkylphenols), plastic monomers (bisphenol A), 
softeners/plastifiers (phtalates), conservation chemicals, cosmetics, and others. 
Although the harmful effects on the environment are already proven today, the 
production of chemicals per year is greater than ever before, reaching actually a level 
of as much as 400 Mio t. Still very little is known about the effects of single 
compounds on wildlife, let alone the effects a whole mixture of these chemicals might 
possibly have.  
 
Possible effects of EDC action on the developing brain  
More and more studies focus on EDC and their potential impact on the regulation of 
target genes via receptor-mediated mechanisms. After binding to the receptor, the 
EDC may act as full or partial agonists or antagonists. Although they may mimic the 
action of natural hormones, very often the effect pattern appears to differ from that of 
natural hormones. The mere complexity of transcriptional regulation by estrogen 
receptors may explain the absence of a direct correlation between the binding affinity 
to a receptor and its transactivation. The whole process is influenced by the steroid 
receptor subtype present, the type of ligand, the available coactivator-corepressor set 
and finally by the subtype of the hormone response element (Kuiper et al., 1998). 
Therefore different substances may generate both, agonistic or antagonistic effects. 
Apart from interactions with hormone receptors, EDC may as well interfere with 
transport proteins, alter the synthesis and bio-transformation of hormones and 
interfere with the delicate regulation of the hypothalamus-pituitary gland-secondary 
glands-axis (see Fig. 12). 
Possible consequences of EDC’s interactions with developmental processes in the 
brain differ depending on the sex. A female brain would be expected to develop in a 
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more masculine way if influenced by an estrogen agonist. The male brain, however, 
has two possibilities to react. Either the effect of the natural estradiol would be 
agonistically reinforced by an EDC, which would result in enhanced masculinisation, 
or a negative feedback effect might occur, that might reduce the testosterone 
secretion, which would then in turn lead to a reduced level of masculinisation. With 
regard to the masculinisation process an estrogen receptor antagonist would have 
the opposite effect. Even more complex situations could occur with partial agonists. 
There, the result depends on the interactions with the natural sex hormone. If the 
intracellular concentration of the natural hormone is high, the partial agonist will act 
like an antagonist, whereas at low concentrations of the endogenous hormone the 
agonistic activity of the partial agonist would become manifest. Estrogenic 
organochlorine pesticides have been shown to promote masculinisation processes in 
male mice (vom Saal et al., 1995). PCB were found to interfere with sexual brain 
differentiation, affecting the activity of aromatase which converts testosterone into 
estradiol in neurons (Hany et al., 1999; Crain et al., 1997; Sanderson et al., 2001, 
2002). Finally the sensitivity of the brain to estradiol could be changed, e. g. by 
decreased expression of estrogen receptors. 
 
Sources of Endocrine Disrupting Chemicals  
There is a wide range of different sources for chemicals acting as EDC (Tab. 1): 
 
• Medicine   
oncologica (Tamoxifen), contraceptives (Ethinylestradiol) 
• Agriculture 
herbicides, fungicides, insecticides (o, p’-DDT) 
• Industry 
flame retardants (PBDE 99), plastic components (Bisphenol A) 
• Plants 
phytoestrogens (Genistein, Coumesterol) 
• Cosmetics 
UV Filter (4-MBC, 3-BC) 
 
 
 
Tab. 1: Possible sources of EDC  
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Based on their similar molecular structure to 17β- Estradiol, the compounds were 
divided into 6 groups: Diethylstilbestrol (DES)-like chemicals, steroids, 
phytoestrogens, diphenylmethans, biphenyls and phenols. The binding activity was 
defined relatively to that of 17β- Estradiol. (Fang et al, 2001) 
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Fig. 14: Molecular structures of endocrine disrupting chemicals compared to 17β-Estradiol  
 
Another possible source of EDC among the huge number of halogenated organic 
chemicals are the increasingly important polybrominated flame retardants. 
Structurally related to the well known PCB they are suspected to have endocrine 
disrupting potential as well. They are in the focus of the present study. The last 
chapter of the introduction thus deals with this lately arising group of chemicals 
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Flame Retardants 
Since mankind discovered the benefits of fire there has as well always been the 
danger of sever burning damages on human property. Therefore big effort has been 
done on finding methods to lower the risk of inflammation of materials. With the 
invention of chemical flame retardants a great breakthrough has been achieved, 
however as e. g. this study shows, the compounds in use do not only have beneficial 
properties. Especially in terms of risk for the environment the long durability of flame 
retardants causes major problems, as they are only very little biodegradable. These 
flame retardants are used as additives in all kinds of polymer materials or are simply 
applied to a material in order to increase the fire resistance of the particular product. 
Within the past 50 years the use of polymers with different properties and 
applications has increased exponentially and they are now found almost everywhere, 
e. g. in clothing, toys, furniture, cars, computers, etc. As these polymers are 
petroleum-based and hence are flammable, flame retardants are applied to 
combustible materials such as plastics, wood, paper, and textiles, in order to 
heighten their flashing point. 
Brominated Flame Retardants 
Due to its heat stability the halogen brome is thought to function as a fire-retardant 
compound. Brominated flame retardants (BFR) are produced via direct brominating 
of organic molecules or via addition of bromine to alkenes and are used in large 
quantities in a wide variety of consumer products.  
Brominated flame retardants can be subdivided into three groups, depending on the 
way how they are incorporated into the polymer structure: brominated monomers, 
reactive flame retardants and additive flame retardants.  
Brominated polymers are produced via polymerisation of prior brominated monomers 
like styrene or butadiene. The subsequent polymerisation process results in a 
polymer containing both brominated and non-brominated monomers. Reactive flame 
retardants, such as tetrabromobisphenol A, are chemically bonded into the plastics, 
whereas additive flame retardants, including polybrominated diphenyl ethers (PBDE), 
are simply mixed with the other polymers, and therefore are more likely to evaporate 
from the products (Hutzinger et al., 1987). 
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Polybrominated diphenyl ethers 
According to the latest information available (Darnerud et al., 2001) the actual global 
production is around 40,000 tons a year. PBDE are subdivided into three groups 
according to the degree of bromination, i.e. Penta-BDE, Octa-BDE and Deca-BDE 
and classified after their average bromine content. They are relatively resistant 
towards physical, chemical, and biological degradation. Their boiling point lies 
between 310°C and 425°C and at room temperature they have a low vapour 
pressure. The higher brominated PBDE are, the more lipophilic and the less water 
soluble they become. 
PBDE are mainly used in textile material and in plastic coatings, with concentrations 
ranging from 5% up to as much as 30%. The general chemical formula is C12HxBryO 
with hydrogen and bromine atoms always being 10 in summary. Within the 
carbohydrate ground structure any of the 10 hydrogen atoms can be exchanged with 
bromine. Thus 209 congeners are possible and according to the nomenclature of the 
structurally related PCB divided into 10 congener groups.  
 
Penta-brominated diphenyl ethers  
PBDE99, the compound of interest in this study, is one of the two most commonly 
used congeners. There are mainly three low brominated PBDE: 2,2’,4,4’-
tetrabromodiphenyl-ether (BDE-47) and 2,2’,4,4’,5-pentabromodiphenyl-ether (BDE-
99) and 2,2’,4,4’,6-penta-BDE (BDE-100) in commercial products. BDE-99 and to a 
lower extent BDE-100 are produced via continuous bromination of the ground 
product BDE-47. A commercial mixture often consists of 35% BDE-99 and 6.8% 
BDE-100, the rest made up by BDE-47. The ortho-para directing property of the 
bromine atoms in BDE-47 and steric hindrance might be the reason for the higher 
amount of BDE-99. All three are of particular interest, because they are found in a 
rising number of biological samples including human tissue (de Witt, 2002). 
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Fig. 15: The general formula of polybrominated diphenylethers  
The polychlorinated biphenyls (PCB) are well known to bio-concentrate and bio-
accumulate in the environment. Because of their structural similarity, their high affinity 
to particles and their lipophilic characteristics, PBDE have been suspected to behave 
and act in a manner similar to that of PCB (Pijnenburg et al., 1995). In fact PBDE 
have been found in various biotic samples from birds, seals, whales as well as in 
human samples such as blood, adipose tissue and breast milk (de Boer et al., 1998; 
Stanley et al., 1991) 
How important PBDE have become as environmental contaminants has been shown 
in a study from Sweden, where the accumulation in human breast milk, with 
constantly increasing concentrations within the last 30 years has been revealed. 
Starting in 1972 at a level of as low as 0.07 ng/g lipid weight rising to as high as 4.02 
ng/g lipid weight in 1998 (Meyronite et al., 1999). Even higher levels have been 
detected in human samples from the USA. There human adipose tissue and milk 
levels of PBDE99 range between 0.01 and 0.3 µg/g lipid with upper levels up to 0.11 
µg/g lipid (She et al., 2002; Schecter et al., 2003; Sjödin et al., 2003) while European 
levels are considerably lower (Sjödin et al., 2003). For Californian harbour seal 
blubber, a mean PBDE99 concentration of 0.112 µg/g lipid was reported, with a 
range up to 0.303 µg/g lipid (She et al., 2002). 
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It is true that PCB concentrations in wildlife are still higher than those of PBDE, but 
after being prohibited some 20 years ago the former are declining over the same time 
period, while levels of the latter compounds are rising. 
Until today, thyroid function has been considered as one of the most sensitive end 
points of PBDE toxicity in vivo. Induction of thyroid hyperplasia and alteration of 
thyroid hormone production have been observed in rats and mice (Darnerud et al., 
1996; Fowels et al., 1996; Meerts et al., 2000) The fact that these phenomena have 
also been observed for other organohalogen compounds with similar structure: the 
PCB and their hydroxylated metabolites (Brucker-Davis, 1998) is a further matter of 
concern and should generate additional research on that issue. The dioxin-like, Ah-
receptor-mediated induction of cytochrome P450 1A1 and 1A2 in vitro (Brouwer et 
al., 1998) and in vivo (Hamberg et al., 1998) is another characteristic that PBDE have 
in common with PCB and the polybrominated biphenyls (PBB). Last but not least the 
metabolised forms of PBDE (after hydroxylation in the liver) possess potential 
biological importance (Meerts et al., 2000). 
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Aim of the present study 
Brominated flame retardants have been identified as environmental contaminants 
with increasing importance on a global scale. Bioaccumulation was demonstrated in 
marine mammals, birds and humans for polybrominated diphenyl ethers (PBDE). 
During the last 10 years, levels in human breast milk have risen to about 4 ng/g lipid. 
Potential targets of environmental chemicals, that are of major importance to 
populations are reproduction and ontogeny. Information on the toxicity of PBDE is 
scarce. However, preliminary experimental evidence suggests adverse effects on the 
developing nervous system. The present investigation is part of a European Union 
(EU) project designed to clarify the potential developmental neurotoxicity of PBDE. 
The pentabromo-diphenyl ether, PBDE99, was chosen, because it is one of the 
congeners typically present in the biosphere. Since PBDE were suspected to have 
effects similar to PCB, which have been shown to interfere with brain development, a 
commercial PCB mixture (Aroclor 1254) was chosen for a comparative study. Certain 
PCB congeners are known to be active at estrogen receptors, and PCB mixtures 
have been found to interfere with reproductive and sexual differentiation processes 
(see Hany et al., 1999). In vitro data suggest that certain PBDE may also interact with 
estrogen receptors (Meerts et al., 2001). Therefore, PBDE99 was studied for possible 
effects on neuroendocrine development. The embryo and fetus is particularly at risk 
with respect to adverse effects of xenoestrogens, because it develops in an 
environment with low endogenous estrogen levels.  
While most of the maternal estradiol does not normally interfere with sexual 
differentiation of the brain, because it is bound to transport proteins and does not 
have access to the fetal circulation, xenoestrogens are bound less tightly to specific 
binding proteins and due to their lipophilicity, readily cross the placenta barrier, enter 
the embryonic circulation and diffuse into the embryonic brain, which lacks a blood 
brain barrier. This way they have the opportunity to interact with receptors in an 
environment with low levels of endogenous estrogen. This may result in altered 
sexual development. 
In the present study, the developmental long-term effect of the polybrominated flame 
retardant PBDE99 was analyzed in two sexually dimorphic brain regions of adult rat 
offspring, the ventromedial hypothalamus (VMH) and the medial preoptic area 
(MPO).  
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We hypothesized that expression and estrogen sensitivity of estrogen target genes 
may be permanently changed by exposure to endocrine active chemicals during 
ontogeny, leading to alterations in sexually dimorphic brain functions. We studied the 
expression of estrogen receptor alpha and beta, progesterone receptor (PR) and 
preproenkephalin (PPE), the precursor of enkephalin. PR and PPE were chosen as 
parameters of estrogen sensitivity. 
Time-pregnant Long Evans rats were treated subcutaneously with either PBDE99 (2 
dose level) or Aroclor 1254 during a defined part of gestation. The subcutaneous 
route was chosen, because the amount of highly pure PBDE99 was limited. During 
postnatal ontogeny, general developmental parameters as well as parameters linked 
with sexual development (i.e. onset of puberty) were monitored in the offspring. In 
adult offspring, expression of mRNAs encoding for PR, PPE and estrogen receptors 
α and β1 was quantified in medial preoptic area and ventromedial hypothalamic 
nucleus by Real Time-PCR. In order to assess possible changes in the sensitivity of 
target genes, part of the male and female offspring was gonadectomized in order to 
reduce and stabilize endogenous hormone levels, and injected with one dose of 
estradiol. The study is expected to provide information on effects of PBDE on sexual 
brain differentiation and, on a more general basis, on the interaction of xenobiotics 
with sexual differentiation processes. 
This represents a novel approach to identify possible developmental effects of 
xenoestrogens in the central nervous system at a molecular level. Behavioral studies 
can then link the molecular findings to the organismic level. Exposure to chemicals 
during sexual differentiation is a matter of concern, because if it takes place during 
sensitive phases, the development of the central nervous system, as well as of the 
reproductive system, could be harmfully affected by exogenous substances even 
below levels of general toxicity. And, while the chemical exposure may be transient, 
its effects may result in permanent alterations of brain structure and function, if the 
exposition takes place within sensitive periods in development. 
Some ethical considerations 
The use of animals for this study requires some observations on the justification for 
this purpose. The aim is to balance the misfits done to the creature with the benefit 
expected from this study. Only after due deliberation it is appropriate to interfere with 
the right of any creature for integrity and life. For the sake of simplicity the following 
considerations are not meant to discuss ethical matters in detail, as there exist 
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already many articles on that issue. In my opinion ethical decisions are always a 
matter of personal perspectives, so this chapter only gives a personal statement on 
how the ethical dilemma discussed above has been handled in this study.  
For achieving the aims of this study, animal experimentations had to be carried out. 
What are animal experiments? A frequently used definition is, these are 
“experiments, that do not serve the individual animal which is taken for to carry out 
the experiment”. That means the particular animal does not have any benefit from the 
experiment it is used for. This certainly is the case in the present study. Why was it 
necessary to use animals? The results of this study demonstrate that not all aspects 
of toxicology can be assessed in in-vitro systems. The effects of PBDE99 could not 
have been predicted from in vitro data. An animal’s body is a three-dimensional 
system with interacting physiological systems, whereas in-vitro systems only are able 
to give first insights into certain chemicals’ impact on selected mechanistic questions. 
The metabolism of an animal may change the chemical´s property, e.g. by making it 
biologically active through liver metabolism.  
Toxicological matters are a special issue with regard to the use of animals. One can 
only choose between two evils: not to gain any knowledge about impact of chemicals 
on nature and mankind by deciding to go without animal experiments. Or, as this is 
fairly unacceptable, to use animal models to learn at least something about effects of 
chemicals on living organisms, in order to assess the risk posed by the use of 
chemicals.  
Once the decision has been taken to use animals for a study, the scientist’s 
responsibility comprises all aspects of the well being of the handled creatures. In 
order to standardize this, “International Guiding Principles for Biomedical Research 
Involving Animals” were formulated in 1985 by The Council for International 
Organizations of Medical Sciences – CIOMS (News Physiol. Sci. 17, Febr. 02, 43-
46). The present investigation was conducted according to the Swiss Law for the 
Protection of Animals and the Guidelines of the Swiss Academy for Medical 
Sciences. 
In principle the guidelines state that the extent of animal suffering is based on human 
analogy. The assessment of the degree of pain is done by watching the animal 
before, during and after the experiment. Pain should be reduced as much as possible 
(in terms of the rules given by the 3R = reduce, replace, refine) to achieve the results. 
In this study, the doses of chemicals applied did not cause clinical signs of toxicity. 
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The animals, that were studied for female sexual behavior were not gonadectomized. 
Formerly ovariectomy followed by treatment with estrogen and progesterone was a 
standard method to create a standardized condition independent of the physiological 
estrous cycle. Instead of this invasive method in this study the less stressing and not 
at all painful method of taking vaginal smears was chosen to ensure that females 
were taken for the behavioral studies always at the same stage of the estrous cycle 
(and thus similar hormone milieu). 
If operative methods have been found to be necessary (e.g. for the estrogen 
challenge part) the surgical manipulation was carried out under anesthesia followed 
by analgesic medication. 
To meet further the needs of the rats used in this study, they were housed in groups, 
as rats are social animals, who like to interact with each others. A standard number 
of 2-3 adult males or, due to their lower size, 3-4 females were housed in one cage. 
Furthermore, in terms of “behavioral enrichment”, they were given the opportunity to 
carry out some of their natural behaviors (exploring the environment, seeking for 
shelter, etc.) by adding plastic rings into the cage. These rings were very well 
accepted by the animals as they were intensely used to climb on them, to rally 
around them, or to sleep in groups inside of them.  
In order to reduce individual stress, the animals were given a period of adjustment to 
handling before using them for experiments. 
Finally the question, whether or not it is justified at all to use animals for experiments 
in environmental toxicology, is in some way obsolete, since in fact all wild living 
animals involuntarily undergo a huge experiment on the impact of chemicals on their 
development as indicated by the high levels of chemicals found in a variety of 
samples from wild animals. The fact that the right of any creature for integrity and life 
is endangered by the massive release of chemicals into the environment by 
humanity, seems to make it indispensable to use animals to learn more about the risk 
of chemicals. Such data from animal experiments serve also the interest of animals.  
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MATERIALS AND METHODS  
A. Animals 
 
Fig 16 Long Evans rat 
 
Long Evans rats (Fig. 16) were bred in our own colony at the Institute of 
Pharmacology and Toxicology, University of Zurich, maintained by the Institute of 
Laboratory Animal Science. The stem of Long Evans rats has been developed in 
1915 by Long and Evans. They bred Wistar albino females with males of the 
wildtype Rattus norvegicus leading to the smart rats with mainly white fur but a dark 
head and a spotted dark line on the back.  
The animals were kept in groups in Macrolon cages (cage type 4, 19 x 38 x 60 cm), 
with a maximum number of 4 females or 3 males. The animal room had a controlled 
light cycle of 14 hours light (2:00 am – 4:00 pm), constant temperature (22 - 23° C), 
and around 40 - 58% relative humidity. Food pellets (Provimi Kliba, Kaiseraugst, 
Switzerland, chow no. 3340) and tapwater was given ad libitum. Rats were marked 
with spots of picric acid. 
 
Mating/Birth 
One receptive untreated female (3-6 months old) was mated with an untreated male 
over night, starting at 4:00 pm. Early next morning, the male was removed and, a 
vaginal smear was taken from the female, to check for presence of sperms. Females 
with sperm-positive smears were kept in groups of up to 4 animals, but separated 
one day before the expected parturition. The day of positive vaginal smear was 
defined as gestational day 1 (GD 1). Pups were born at GD 23, which was defined as 
postnatal day 1 (PN 1). In order to standardize postnatal conditions (feeding, etc.), 
littersize was adjusted to 8 to 10 pups. If necessary, surplus pups were marked and 
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added to litters with less than 8 pups. These additional pups were not used for further 
analyses. Weaning and separation of sexes was carried out on PN 28. 
 
B. Chemicals 
 
PBDE 99 (2,2’,4,4’,5-Pentabromodiphenylether, purity > 99%) and Aroclor 1254 
(commercial PCB-mixture) were obtained from Promochem GmbH, Wesel, Germany.  
 
C. Treatment 
 
PBDE99 was dissolved in a few drops of toluene and further dissolved in olive oil, 
Aroclor 1254 was dissolved in olive oil. The toluene from the PBDE99 solution was 
evaporated over night on a magnetic stirrer. Olive oil served as vehicle control. 
 
Time-pregnant rats were subcutaneously injected daily with PBDE 99 (1 or 
10mg/kg/day), Aroclor 1254 (10 or 30 mg/kg/day), or vehicle (olive oil) from 
gestational day (GD) 10 to GD 18 (9 injections). Injections were carried out in the late 
morning. 
C 1. Steady state conditions (Baseline) 
In the baseline experiment under steady state conditions, the F1 offspring received 
no postnatal treatment. Male and female offspring were sacrificed at 4 months of age 
(120 days). The estrous cycle of females was monitored in the morning by daily 
vaginal smears, females were always sacrificed in metestrus (= diestrus 1). It should 
be noted that the offspring continued to be exposed to either PBDE99 or Aroclor 
1254, since both bioaccumulate. Exposure to PBDE99 was confirmed at 120 days of 
age by chemical-analytical analysis. 
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Schematic overview: Baseline experiment 
 
 †
GD10 GD18 
Mating 
Birth 
   GD23=PN1 
Developmental 
Landmarks 
?Survival Rate 
?Onset of puberty 
PN50
PN120 
9 s.c. 
 injections 
 
Steady state conditions: 
?Estrous cycle 
?Female sexual behavior 
?mRNA levels of estrogen target 
genes in rat brain: VMH + MPO 
 
PBDE 99: 
1 mg/kg/d 
10 mg/kg/d 
Aroclor 1254: 
10 mg/kg/d 
30 mg/kg/d 
Olive oil as Control 
Fig. 20 Study design for steady state conditions. The parental generation was exposed to the test 
compounds by 9 s.c. injections from gestational day 10 to 18. 
C 2. Acute estrogen challenge  
At PN 70 = 10 weeks of age the F1-animals were gonadectomized. After a recovery 
period of 2 weeks, the animals were given a single subcutaneous injection of either 
17β-Estradiol (E2) (Calbiochem Lucerne, Switzerland, dissolved in a few drops of 
ethanol and oliveoil) 10 µg/kg bodyweight, or of the vehicle. 6 hours later the animals 
were sacrificed. 
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Schematic overview: Acute estrogen challenge experiment 
 
 
Gonadectomy 
 
† Mating 
Birth 
GD23=PN1 PN70 PN84 GD10 GD18
9 s.c. 
Acute estrogen-challenge 
?6h after single s.c. injection  
of 17ß-Estradiol or vehicle 
?mRNA levels of estrogen target  
genes in rat brain (VMH + MPO) 
 
PBDE 99: 
1 mg/kg/d 
10 mg/kg/d 
Olive oil as Control 
Fig. 21 Study design of the acute estrogen challenge. The animals were exposed to the test compounds 
in the same way as the steady state animals. On PN 70 (at the age of 10 weeks) F1-animals were 
gonadectomized. The animals were allowed a recovery time of two weeks and then injected with 
vehicle or estradiol (10 µg/kg s.c.) and killed six hours after injection. 
For gonadectomy the offspring were anesthetized with a combination of fentanyl, 
fluanisol, meditomidine and atropine according to the protocol of the Institute of 
Laboratory Animal Sciences, University Zurich (Table 2). Injection volume was 
150µl/100g body weight s.c.. 
 
Component Volume 10 ml 
Fentanyl citrate and fluanisone (Hypnorm, Janssen) 1,25 ml 
Medetomidine (Domitor, Pfizer) 1,25 ml 
Atropinsulfate 0,1% (Atropin, Kantonsapotheke Zurich) 0,25 ml 
Tap water 7,25 ml 
Tab. 2 components of anesthetic cocktail 
 
Females were placed on the side on a sterilized plate. The skin was disinfected with 
70% ethanol. On either side a 10 mm craniocaudal skin cut was made and the 
abdominal muscles were divided. The ovaries were taken out and pinched off from 
the fallopian tube with a clamp before truncating. Subsequently the muscles and the 
skin were sown up (Supramid 1.5 metric DS19, B. Braun Medical AG, Switzerland). 
Males were placed on their back on the sterilized plate. The skin of the scrotum was 
disinfected, in the middle of the scrotum a 10 mm cut was made with a scalpel and 
39 
 MATERIALS AND METHODS    
for both sides the pellicle around the testis was removed. Than the testes were pulled 
out and pinched off with a clamp. On each side a ligation of the vas deferens was 
made, in order to prevent blood loss, before cutting off the testis. Subsequently the 
ligated end was placed back into the scrotum, which was then closed with two nodes 
of thread. 
 
 
D. Developmental analysis 
 
After birth different developmental endpoints were investigated at fixed ages such as 
weight gain, righting behaviour, anogenital distance. 
 
Protocol: 
- At postnatal day 2 (PN 2), 4, 6, 8, 9, 12, 13, 14 and 15 the pups were weighed. 
- At PN 2, 4, 6, 8 and 9 righting behaviour was tested. 
- At PN 2, 6 and 14 anogenital distance was measured. 
- The opening of eyes was checked from PN 12 until the complete opening of both 
eyes. 
- At PN 28 the offspring were weaned from the mother. Males and females were 
housed separately with a maximum number of 3 to 4 per sex (minimum 2, because 
rats are social animals). 
- The onset of puberty was studied in females from PN 34 (vaginal opening) and from 
PN 41 in males (preputial separation). 
 
 
Estrous Cycle  
The estrous cycle of rats normally comprises four days and is characterized as 
proestrus (Pro), estrus (Est), metestrus (diestrus 1 = D1) and diestrus (diestrus 2 = 
D2) identified by cytology of vaginal smears (Long and Evans, 1922, Marcondes et 
al. 2002) (Figs. 17 and 18). Vaginal smears were taken every day at around noon, 
stained with toluidinblue, and examined to determine the stage of the estrous cycle 
(Fig. 18). Ovulation occurs during the night between proestrus and estrus. During this 
time, the female is receptive and will accept males. To standardize experimental 
conditions, only females in proestrus were taken for behavioural experiments. 
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Rat estrous cycle
D1 D1 D2 D2 Pro Pro Est Est D1
Progesterone Estrogen LH FSH
 
Fig 17 Hormone levels throughout rat estrous cycle (Fig. according to Marcondes et al. 2002) 
Most of the animals displayed regular cycles, but there were a number of animals 
with irregular cycles showing extended proestrus/ estrus stages or non-cyclic 
characteristics.  
Proestrus (Pro) Metestrus (D1) 
Diestrus (D2) Estrus (Est) 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18 Cell types throughout estrus cycle in Long Evan rats (see text for details) 
41 
 MATERIALS AND METHODS    
Proestrus (Pro): The vaginal epithelium is thick and the follicles grow rapidly. The 
vaginal smear contains numerous small, nucleated epithelial cells, often in clusters 
and sometimes a few leucocytes. 
Estrus (Est): The follicles grow to their maximum size. The smear contains large, 
anucleated cornified cells, partly in clusters. No leucocytes can be observed. In this 
state, progesterone is secreted from the corpus luteum. During early estrus, ovulation 
takes place. 
Metestrus (Diestrus 1 = D1): In metestrus, leucocytes and very few small epithelial 
cells can be found in the smear. Here the levels of sex-hormones are low. 
Diestrus (Diestrus 2 = D2): In this state of the estrous cycle, the follicles grow 
continuously. Numerous leucocytes and some small epithelial cells are to be found in 
the smear. In the Long Evans strain used in the present study, leucocyte number 
reached its maximum on D2. 
E. Behavioural experiments  
To test whether the changes in gene expression levels in brain regions (see chapter 
“Results”) may have consequences at the functional level, a total number of 9 
females each for controls and the high dose group of PBDE99 (P10) were tested for 
sexual behaviour. 
At usual mating time, at around 4:00 pm, a normal, vigorous male taken from the pool 
of breeding animals was mated with either a control female or a P10-treated female 
in a cage (type 4), which is identical to the regular housing cage of the animals. The 
cover metal grid was removed, and replaced by a plexiglas attachment in order to 
heighten the walls to prevent the animals from escape. The video camera was 
positioned vertically above the cage. The animal room was illuminated by an infrared 
light source (Panasonic CCTV Camera, Model: WV-BP310/G) in order to record the 
activities with a special infrared camera (Fig. 19). Each experiment was recorded for 
30 minutes in the late afternoon. All the females were tested with untreated males, 
chosen randomly from the pool of breeding animals, to assure, that experienced 
males were taken. Between subsequent experiments, the males were given a pause 
of at least four days to recover. Females were tested in proestrus. At around noon, 
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vaginal smears were taken to assess the stage of estrous cycle based on cytology 
(Cooper et al., 1993). 
 
Observation Equipment 
 
 
4
2
3
5
1
 
 
 
 
Fig. 19 behavioural experiment´s set up: observation chamber (1), infrared camera (2), red light (3), video
recorder (4) and monitor (5) 
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Determination of behavioural parameters 
The videotapes were evaluated by counting the occurrence of the behavioural 
parameters listed below. In order to standardize the procedure of observation, it was 
carried out on coded tapes, without knowing the treatment group of the observed 
animal. 
 
The following behaviours were evaluated: 
LME: Lordosis with ejaculation   
The male mounts the female, which displays lordosis. Successful intromission 
and ejaculation occurs. Indication for a successful performance is licking and 
cleaning activity of the male immediately following the ejaculation. 
LOE: Lordosis without ejaculation 
Male mounts the female, the female is displaying lordosis but no intromission 
occurs. No genital licking by the male. 
MOL: mounting without Lordosis 
Male mounting the female, but this does not display lordosis. No intromission 
occurs. 
J&W: Jumping and wiggling   
Female moves repeatedly in short jumps in front of the male and wiggles her 
ears. Characteristic for that behaviour is the straight tail and bent ears of the 
female. 
LH: Licking head 
Female licks or sniffs head or neck of the male. 
LG: Licking genitals 
Female licks or sniffs male’s genitals. 
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F. Molecular biological methods 
1. Determination of mRNA levels of estrogen regulated genes in two sexually 
dimorphic brain regions: 
The F1-animals were sacrificed by decapitation by an animal guillotine in short-term 
ether anesthesia. Females of the steady state series were taken in Diestrus 1 as 
described above. 
The brain was quickly removed, frozen on dry ice and stored at –80°C until molecular 
biological analysis. Cross sections of 300 µm thicknesses were cut in a Leitz 1720 
cryostat equipped with a special knife, at the level of the medial preoptic nucleus 
(MPO) and of the ventromedial hypothalamic nucleus (VMH). The anterior-posterior 
development of the commisura anterior and the evolving 3rd ventricle were used for 
orientation. From these tissue slices, pieces containing MPO were cut with a scalpel, 
those containing the VMH with a preparation needle. (Fig. 22) 
 
7 
6 
5 
4 
3
2
1 
 (A)          (B) 
Fig. 22: Frontal brain slides with MPO (A) and VMH (B) (4,84x) 1: Corpus; 2: Commissura
anterior; 3: nucleus caudatus putamen; 4: Radiatio corporis callosi;  5: capsula interna; 6: fimbria
hippocampi; 7: tractus opticus 
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2. RNA Isolation 
The tissue samples were homogenized in RLT Lysis Buffer from QIAGEN (Basel, 
Switzerland) (5mg tissue/350µl Lysis Buffer), in a Polytron-rotor. 
Total RNA was isolated following the procedure and using the reagents of the 
RNeasy mini Kit 250 (cat. No. 74106, QUIAGEN), plus a DNAse step.  
For the reverse-transcription an RT-kit from Applied Biosystems (Rotkreuz, 
Switzerland) was used. 
 
Homogenisation of the brain tissue 
Brain pieces containing either MPO or VMH were put into Eppendorf tubes containing 
RLT buffer, 10µl ß-mercaptoethanol per 1 ml buffer. Tissues were homogenized in a 
rotor-stator homogenizer (Polytron, Kinematica, Lucerne, Switzerland) for 30 sec at 
room temperature and immediately centrifuged for 10 min at 3000 x g. The clear 
supernatant was stored at – 80°C. Between subsequent homogenisations the 
homogenizer was washed twice with water and one time with RLT-buffer. 
 
RNA-Extraction  
Total tissue ribonucleic acid (RNA) was extracted with the QIAGEN RNeasy-mini kit. 
After thawing the frozen probes they were centrifuged for 2 minutes at maximum 
speed (13000 rpm) to ensure that only clear solution was taken for the ongoing 
procedure. A total of 350 µl clear homogenate was added to 350 µl of 70 % ethanol 
and mixed carefully by pipetting up and down. 
The 700 µl sample was put on a RNeasy mini column placed in a 2 ml collection 
tube. After 15 sec of centrifugation at 13000 rpm the eluate was discarded.  
350 µl RW1 buffer was added to the centre of the column and the column was 
centrifuged for 15 sec. at 13000 rpm. The eluate again was discarded. 
In order to quantify only mRNA by reverse transcription polymerase chain reaction 
(RT-PCR) any genomic desoxyribonucleic acid (DNA) must be quantitatively 
removed. Therefore the RNA samples were carried through a DNA-digesting step 
with RNase-free DNase 1-set (QIAGEN). DNase 1 was dissolved in 500 µl RNase-
free water and then gently mixed by pipetting up and down. 20 µl aliquots were kept 
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at -20°C. Before use, 140 µl RDD buffer was added to one 20µl aliquot. Each RNA 
sample was incubated at room temperature for 15 min together with 80 µl DNase 1 
preparation. After that, 350 µl RW 1 buffer was added, and the probe was centrifuged 
for 15 sec at 13000 rpm. The collection tube including the eluate was discarded; the 
column was transferred to a new 2 ml collection tube. 500 µl of RPE buffer, mixed 
with ethanol, was pipetted onto the column and centrifuged for 15 sec as described 
above. The eluate was discarded. Once again 500 µl RPE buffer was added on top 
of the column and centrifuged for 2 minutes at maximum speed. 
For elution of total RNA, the RNeasy column was transferred to a new 1.5 ml 
collection tube and 30 µl RNase free water was added on top of the column. The 
column was centrifuged for 1 min at 13000 rpm and the sample of total RNA in the 
collection tube was immediately stored at -80 °C until use. 
 
3. Reverse Transcription  
To get a template for the final real time PCR procedure, and because it is more 
stabile than RNA, the RNA samples are reverse transcribed into cDNA. First, the 
master mix was prepared according to the table below. Then 20 µl RNA sample was 
added to each tube containing 80 µl of this mastermix. The samples were placed in a 
PTC-100 Programmable Thermal Controller (M Research Inc.), and the RT PCR 
reaction carried out under the conditions described in table 2. 
As a result the complete set of RNAs in the two brain regions has been copied to 
cDNA. The samples were stored at –20°C until use for real time PCR. 
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Mastermix Total volume 100ml Final concentration 
H2O 28.5  
10x TaqMan RT buffer 10 1x 
25mM MgCl2 22 5.5mM 
Deoxy NTP mix 20 500mM of each NTP 
Random Hexamers 5 2.5mM 
RNAse Inhibitor 2 0.4U/ml 
MultiScribe TM RT 2.5 1.25U/ml 
RNA in H2O  10 1pg-20ng/ml 
 
 
 
RT Conditions
incubation RT RT inactivation end
10 min 30 min 5 min ...
25 °C 48°C 95°C 4°C
Tab. 3 Master mix ingredients and conditions for reverse transcription  
 
4. real time PCR  
real time PCR is a skilful technique to quantitatively analyse the transcribed cDNA. 
Quantification is carried out by amplifying specific nucleic acid sequences using 
specific oligonucleotide primers and a DNA polymerase enzyme. This method does 
not require any post-PCR processing such as gel electrophoresis, for the 
quantification of the amplified product can be done at any point during the PCR 
cycles. Like in normal PCR, gene-specific forward and reverse primers are used. In 
addition, in real time PCR another specific oligonucleotide is introduced, which is 
labelled at its 3’ and 5’ end with a reporter fluorophor (FAM) and a quencher 
fluorophor (TAMRA), respectively. The quencher suppresses the reporter signal as 
long as it is located next to it. This TaqMan probe is designed to hybridise at the 
amplicon site between the two specific primers. During the amplification process the 
exonuclease activity of the polymerase enzyme leads to a cleavage of the TaqMan 
probe and the reporter fluorophor is spatially separated from the quencher. Thus the 
quencher fluorophor no longer suppresses the fluorescent signal from the reporter 
and the emitted fluorescence can be detected. A laser is used to excite the electrons 
from the fluorescein molecules (Fig. 23) 
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The real time PCR reaction and the resulting amplification plot have a sigmoidal 
shape. Three different phases can be observed: a background phase at which the 
fluorescence signal is masked by the background signal of either machine or 
reaction, an exponential phase in which the amount of cDNA is doubling within each 
cycle of the ongoing reaction, and a plateau phase. During the background phase, 
the signal of the PCR product is below the background signal. As soon as a sufficient 
amount of product has been amplified and can be detected, the signal exceeds the 
background and the exponential phase starts. In this phase the amount of cDNA 
doubles within one cycle. The reaction is finished, when no further amplification takes 
place. Then the plateau phase, in which the slope of the curve is tending towards 
zero, is reached. 
The Ct value (threshold cycle) is defined as the point where the signal of the reporter 
exceeds the background. This is also the starting point of the exponential phase. 
With this Ct value the exact amount of product (this is the amount of gene specific 
cDNA) at the beginning of the amplification can be calculated. The lower the Ct-value 
is, the higher the initial amount of cDNA was. 
In order to balance different efficiencies in the RNA extraction step, the level of 
mRNA of the gene of interest is normalized to the amount of a housekeeping gene, 
which is stable and remains largely unchanged by chemical treatment. Thus the 
housekeeping gene serves as an internal reference. 
For real time PCR quantification, the ABI PRISM 7700 Sequence Detector (Applied 
Biosystems) was used, which consists of a 96-well thermocycler, argon laser and 
CCD camera. Samples were analysed with the ABI 7700 Sequence Detector 
software (Lie et al. 1998). 
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Fig. 23 real time PCR plot with exponential curves of cDNA amplification with background phase
(cycles 0 to 16) exponential phase (cycles 16 to30) and plateau phase (cycles 30 to 50)
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Fig. 24 During one amplification cycle of PCR forward (fp) and reverse primers (rp) 
hybridize to the fitting sequence of the target DNA. The TaqMan probe hybridizes in 
between of them. With its 5’-nuclease property the Polymerase enzyme cleaves the TaqMan 
probe thus the reporter dye (R) and quencher dye (Q) are being separated, resulting in 
fluorescence of the reporter. (R). 
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Master Mix µl Final concentration 
TaqMan Universal PCR Master Mix (2x) 12.5 - 
Forward Primer 2.5 300 nM 
Reverse Primer 2.5 300 nM 
TaqMan probe 2.5 125-150 nM 
DNA sample 2.5 - 
H2O 2.5 - 
Total 25 - 
Tab. 4 real time PCR Master Mix agents 
Procedure 
For the analysis a 25 µl reaction volume was used, consisting of 2.5 µl of each cDNA 
sample and 22.5 µl Mastermix, containing H2O, forward and reverse primer (300 nM 
each) and TaqMan probe (225 nM) (Table 4). The real time PCR reactions were 
carried out in 96-well reaction plates with optical caps (Applied Biosystems). The 
arrangement of samples on the plates is shown in Fig. 25. For calculation a standard 
curve was generated with four concentration points, pipetted in triplicates for the 
gene of interest, and another one of the same type for the reference gene cyclophilin 
A. The 72 wells left were filled with the samples according to the scheme given in Fig. 
25 
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1 2 3 4 5 6 7 8 9 10 11 12 
A
B
C
D
E
F
G
H
9 females, 2 replicates 
9 males, 2 replicates 
standard curve, 4 concentrations, 3 replicates 
Cyclophilin A  
gene of interest 
Fig. 25 optical plate with 96 wells: arrangement for comparison of gene expression in males and females 
 
This way it was possible to test 18 samples within one run on one plate. To be able to 
detect possible sex differences I decided to put samples from 9 males and 9 females 
of one treatment group and one brain region onto one plate. The real time PCR 
reaction was then performed on the ABI PRISM 7700 real time thermocycler (Applied 
Biosystems). PCRs were started at a hold temperature of 50°C for 2 minutes, 
followed by 95°C for 10 minutes. Then the reaction underwent 40 cycles, each with 
95°C for 15 s followed by 60°C for 60 s. 
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real time data analysis  
Results were analyzed using Sequence Detector Software SDS 2.0 (Applied 
Biosystems). When the reaction was finished, the threshold line was manually set in 
the linear region of the curves above the background reaction, and the threshold 
cycle (Ct) was defined as the cycle number at which the threshold line crosses the 
amplification plot. Further analyses were then done in Microsoft Excel®. As the 
amplification efficiencies of the reference gene and the target gene were not equal, 
as revealed by different slopes of the exponential phase and different maxima for 
fluorescence in real time PCR, the standard curve method was chosen. To obtain 
standard curve plots cDNA of an RT sample of total brain from control animals was 
plotted for either gene on a 96 well plate taking 4 measurement points with triple 
replicates each and a dilution factor of 1:2. 
Standard curve for reference gene and target gene 
target gene:  y = -3,622x + 25,794
                           R2 = 0,9994
reference gene:  y = -3,3142x + 19,928
                         R2 = 0,9984
18
20
22
24
26
28
30
-1 -0,9 -0,8 -0,7 -0,6 -0,5 -0,4 -0,3 -0,2 -0,1 0
log cDNA amount
ct
-v
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Fig. 26 Example of a standard curve of a reference gene (cyclophilin) and a target gene 
The general standard curve formula is y = mx + q. Y represents the Ct-value, m the 
slope of the standard curve line, x stands for log cDNA amount, q for the y-intercept 
of the standard curve line. The cDNA amount is calculated as 10^x, where x means 
(y-q) / m 
To quantify the cDNA amount of the target gene, the target gene reading is 
normalized to that of the reference gene cyclophilin. i.e., the target gene cDNA 
amount is divided by the cyclophilin cDNA amount. cDNA amounts of target gene 
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and cyclophilin, are calculated from the Ct-value of each experimental sample using 
the standard curves for both genes of the particular run.  
Values of mRNA shown for a target gene in a given tissue thus represent values 
relative to the amount of the reference gene. 
 
 
Bla 
Blabl
a 
 CT
Fig. 27 real time PCR curve shape: the real time PCR reaction basically consists of three 
stages, an early baseline phase representing the background noise, an exponential phase and 
a plateau phase. The cycle in which the sample exceeds the threshold is called threshold 
cycle (CT). The CT value gives the exact amount of gene specific cDNA. The no template 
control is a sample, in which there is no cDNA. Therefore it never exceeds the baseline 
signal. Delta Rn is directly linked to the amount of fluorescence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
 MATERIALS AND METHODS    
Primer and TaqMan probe design 
The Gene Bank of NCBI organisation served as source for mRNA sequences 
for all genes (http://www.ncbi.nlm.nih.gov). Primers and TaqMan probes were 
designed with PrimerExpress Software, version: 2.0 (Applied Biosystems). All 
primers as well as the probes were synthesized by Microsynth (Balgach, 
Switzerland). TaqMan probes were labelled with FAM (6-carboxyfluorescein) 
at the 5´ end as the reporter and TAMRA (6-carboxytetramethylrhodamine) at 
their 3' end as the quencher. Primer and probe concentrations were 
optimized according to the instructions given by the company (ABI Prism 
“User Bulletin 2”). The design of primers and TaqMan probes was carried out 
according to the following criteria:  
Primers: The G/C content spans a range of 30-80 %; the melting point is around 58-
60°C; the nucleotide at its 3' end is G or C, the optimal length is about 20 bases. 
TaqMan Probe: 5' end has to be C, A or T, no G; the number of C bases is higher 
than G bases; the amount of G and C bases together is around 30-80 % and the 
melting point is around 68-70°C. 
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Primer and probe sequences used for real time PCR:  
Forward Primers (FP), Reverse Primers (RP), and TaqMan Probes are listed with the 
corresponding GenBank Accession Number for the following genes: Estrogene 
receptor (ER) alpha and beta, Progesterone receptor (PR), Preproenkephalin (PPE) 
and Cyclophilin (Cyc). The sequences of PR, ER and Cyc were kindly provided by 
coworkers from our laboratory. 
Primer and probe sequences 
FP: 5'-CCAAAGCCTCGGGAATGG-3' 
RP: 5'-AGCTGCGGGCGATTGAG-3' Estrogene Receptor alpha (NM012689) 
 Probe: 5'-TCGTTCCCTTGGATCTGGTGCAACAA-3' 
FP: 5'-TTGGTGTGAAGCAAGATCACTAGAG-3' 
RP: 5'-AACAGGGCTGGCACAACTG-3' Estrogene Receptor beta (NM012754) 
 Probe: 5'-CCACTAAGCTTCCTCTTCAGTGTCTCTCTGTTTACA-3' 
FP: 5'-GCAATTGGCTTAAGACAGAAAGG-3' 
RP: 5'-ACAAGATCATGCAAGCTGTCAAG-3' Progesterone Receptor (NM022847) 
 Probe: 5'-CCCAGTTCACAACGCTTCTATCAACTTACAAAAC-3' 
FP : 5`-AGCTACCTGCGCCATCTGAA-3` 
RP : 5´-CCAGATGCAAAGTCTCAGGAACT-3´ Preproenkephalin (M28263) 
 Probe : 5´-AACGCAGCCCCATGGCG-3´ 
FP: 5'-TGTGCCAGGGTGGTGACTT-3' 
RP: 5'-TCAAATTTCTCTCCGTAGATGGACTT-3' Cyclophillin A (M19533) 
 Probe: 5'-CCACCAGTGCCATTATGGCGTGT-3' 
Tab. 5 Accession numbers and sequences of primers and TaqMan probes of the different genes used for real time 
PCR (FP = forward primer, RP = reverse primer, Probe = TaqMan probe, A = Adenine, C = Cytosine, G = 
Guanine, T = Thymine, 5´ = 5´-end, 3´ = 3´-end) 
 
 Steady state condition Acute estrogen challenge
 VMH MPO VMH MPO 
PR x x x x 
ER alpha x x - - 
ER beta X x - - 
PPE x x x x 
 
Tab. 6 synopsis of mRNA species analyzed in different parts of the project: 
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G. Tissue levels of PBDE99 
In order to determine the tissue levels achieved by the treatments samples were 
analyzed (by EUKOS, Plön, Germany). The samples were worked off in this 
laboratory in a 7+2-mixture of hexane/isopropanol. The extract then was analyzed by 
capillary gas chromatography with mass spectrometry in single ion detection mode 
(GC/MS-SIM).  
 
 
H. Statistical analysis 
 
Data from the different treatment groups, including the vehicle control, were analysed 
using analysis of variance (ANOVA) followed by pairwise comparison with Bonferroni 
correction (SYSTAT software version 5.02). Significance (with p < 0,05) is indicated 
by asterisks. 
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I. Instruments and Chemicals 
 
Instruments 
 
Infrared Camera:  Panasonic CCTV Camera, Model: WV-BP310/G 
Microcentrifuge:  Eppendorf Cenrtifuge 5415D 
Reverse Transcription: PTC-1000 
Realtime PCR:  ABI Prism 7700 Sequence Detector 
Videotapes:   VHS Broadcast Master E180 
Homogenizer:  Polytron, Kinematica, Lucerne, Switzerland 
 
Chemicals and disposables  
 
Aroclor1254   commercial PCB-mixture (Promochem, Wesel, Germany) 
PBDE99   2,2’,4,4’,5-Pentabromodiphenylether, purity > 99% (ditto) 
Taq Man   Taq Man Universal PCR Master Mix Roche 
Dnase   Rnase free Dnase Set QIAGEN 
RLT buffer   Lysis buffer QIAGEN 
EtOH    Fluka 
Pipette tips    Biosphere Filter Tips (RNase free), Sarstedt 
Tubes    Sarstedt 
RDD buffer   Rnase free Dnase set QIAGEN 
Rt PCR wells  96 well optical plates, Applied Biosystems (AB) 
RT Set   Taq Man Reverse transcription Reagents (AB)  
RW1 buffer   wash buffer QIAGEN 
RPE buffer   220 ml RPE buffer (QIAGEN) + 55 ml EtOH 100% 
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RESULTS 
To investigate the developmental neuroendocrine toxicity of PBDE99 at functional 
and molecular levels PBDE 99 (2,2’,4,4’,5-PentaBDE, 1 or 10 mg/kg/day) was 
administered s.c. to time-pregnant Long Evans rats from gestational day 10 to 18 
(vehicle control olive oil). Several developmental landmarks have been studied and 
mRNA levels of several sex hormone-regulated genes were quantified by real time 
PCR (cyclophilin as reference gene) in two sexually dimorphic brain regions, involved 
in control of sexual behavior and gonadal regulation, ventromedial hypothalamic 
nucleus (VMH) and medial preoptic region (MPO). Prenatal exposure to PBDE99 
was studied first under steady state conditions and in a subsequent experiment with 
an acute challenge setup. Finally female sexual behavior was studied in the 10 
mg/kg PBDE99 group. Table 1 shows the total number of tested rat F1 offspring. 
Treatment group Number of females Number of males Number of litters 
Controls (C) 18 20 9 
PBDE99 1mg/kg (P1) 12 14 7 
PBDE99 10mg/kg (P10) 10 22 9 
Aroclor1254 10mg/kg (Aro10) 13 20 5 
Aroclor1254 30mg/kg (Aro30) 6 12 4 
Tab. 7 number of animals and number of litters 
 
A. General toxicity data 
1. litter size and sex ratio 
The slight changes amongst the different treatment groups in litter size as well as in 
the sexratio appeared not to be significant.  
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Fig 28 littersize of the different treatment groups 
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Fig. 29 sex ratio of the different treatment groups 
 
2. Survival rate 
Except for 30mg/kg of Aroclor 1254, the chemicals did not affect the survival rate of 
prenatally treated offspring in the dose range examined. This indicates that there are 
no general toxic effects of the substances tested. In the Aro30 group, the survival 
rate appeared to be reduced but this effect was not statistically significant, possibly 
because of the small litter number. Since later, at an age of about 5 weeks, some of 
the exposed female offspring suddenly died, the experiments with this dose were 
discontinued. 
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Fig. 30 survival rate of all offspring surviving at least until PN14 as percentage of alive born animals. Controls 
(C), PBDE99 1mg/kg/d (P1), PBDE99 10mg/kg/d (P10), Aroclor1254 10mg/kg/d (Aro10) and Aroclor1254 
30mg/kg/d (Aro30). Mean values +/- S.E.M., n see table 7 
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3. Body weight 
Adult body weight also serves as a parameter for the detection of possible general 
toxic effects. 
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Fig. 31 Body weights of adult female offspring in different treatment groups. Mean +/- S.E.M., for n see table 7 
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Fig. 32 Body weights of adult male offspring in different treatment groups. Mean +/- SEM, for n see table 7 
 
Figures 31 and 32 show that also from the point of view of body weight in early 
adulthood there is no evidence for general toxicity in adult offspring.  
 
4. Adipose tissue levels 
Treatment with 1 or 10 mg/kg resulted in the following PBDE99-levels in rat offspring 
(analyzed by EUKOS, Plön, Germany): 
Neonatal brain 0.04 +/- 0.02 µg/g lipid (n=2), and 0.21 +/- 0.006 µg/g lipid (pooled 
brains). Adipose tissue of 120 day-old adult offspring 0.42 +/- 0.14 µg/g lipid (n=2), 
and 7.4 +/- 3.0 µg/g lipid (n=11) (males + females combined). 
 
 
61 
 RESULTS   
B. Endocrine development 
1. Anogenital distance 
Absolute as well as relative anogenital distance exhibited no significant changes in 
different treatment groups. 
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Fig. 33 Absolute anogenital distance of offspring in different treatment groups. Mean +/- SEM, for n see table 7 
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Fig. 34 Relative anogenital distance of offspring in different treatment groups. Mean +/- SEM, for n see table 7 
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2. Reflexes (righting) 
Offspring were positioned on their back to test for reflexes. When they were turning 
back within 6 seconds they were considered as positive. The Aro30-treatment tended 
to reduce this reaction. 
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Fig 35 righting behavior of offspring in different treatment groups. Ratio positive animals, for n see table 7 
 
3. Onset of puberty 
Prenatal treatment with both, PBDE99 (10 mg/kg/day) and Aroclor 1254 (30 
mg/kg/day) significantly (p < 0.05) delayed the onset of puberty in female offspring 
(table 8). Male puberty was slightly but significantly (p < 0.05) advanced by Aroclor 
(10 mg/kg/day), and a similar tendency was noted with 1 mg/kg/day PBDE99 (p < 
0.05) and 10 mg/kg/day PBDE99 (p < 0.01), (table 9). 
Vaginal opening (VO)   
     
females aver. Stdev. aver. stdev. 
  PN   weight   
C 39,55 1,33 116,43 7,55
Aro 10 39,13 1,41 104,65 20,76
Aro 30 41,92 2,75 73,30 26,90
P 1 40,16 1,91 122,17 6,79
P 10 40,89 2,67 123,35 9,86
Tab. 8 Onset of puberty (females) and bodyweight at vaginal opening 
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preputial separation (PS)   
     
males aver. stdev. aver. stdev. 
  PN   weight   
C 47,64 1,17 182,34 12,36
Aro 10 46,72 1,45 171,99 21,34
Aro 30 48,00 2,00 160,99 13,01
P 1 46,62 1,32 172,53 15,46
P 10 46,33 1,35 172,50 14,76
Tab. 9 Onset of puberty (males) and bodyweight at preputial separation 
 
4. Eyes opening 
At PN14 the opening of the eyes was examined. The low dose of PBDE99 happened 
to delay, whereas the high dose of Aroclor1254 advanced that developmental 
parameter. The other treatments did not have a significant effect.  
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Fig. 36 Ratio of offspring with open eyes at PN14 in different treatment groups. Mean +/- SEM, for n see table 
7. Significant changes are indicated by asterisks (p< 0.05) 
 
C. Sexual functions in adult offspring 
1. Estrous cycle in baseline F1 females 
To detect a possible impact on the control of the gonadal axis in exposed F1 females, 
their estrous cycles were examined with regard to their regularity. Vaginal smears 
were taken for 21 days. Cycles exhibiting 4 or 5 days of recurrent cycles respectively 
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were classified as regular. Then the percentage of cycles with no detectable 
regularity were calculated. The results show that exposure to PBDE99 at both 
dosage levels, as well as exposure to the PCB-mixture Aroclor1254, had severe 
consequences. In all prenatally treated females the estrous cycle was extensively 
altered. 
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Fig. 37 Percentage of regular estrous cycles in different treatment groups. C = controls, P1 = 
PBDE99 1 mg/kg/d, P10 = PBDE99 10 mg/kg/d, Aro10 = Aroclor1254 10 mg/kg/d, Aro30 = 
Aroclor1254 30 mg/kg/d 
 
2. Female sexual behaviour 
Female sexual behaviour was analyzed in proestrus defined by vaginal smear. 
Females were mated with an untreated, sexually experienced male. Except for 
“licking head” and “licking genitals” behaviours (LH + LG), sexual behaviour was 
markedly altered by PBDE99 (Fig. 38). Female approaching behaviour towards the 
males, like jumping and wiggling, was dramatically reduced. Since the lordosis 
reaction, a receptive behaviour of the female, is independent of the male ejaculatory 
behaviour, the lordosis quotient (LQ) is calculated by dividing the number of 
behaviours, in which lordosis occurs (LME, LOE and MOL), by the total number of 
mounts. The lordosis quotient was significantly lower in PBDE99-exposed offspring 
as compared to the control group. Thus the evaluation of female sexual behaviour 
revealed PBDE99-induced changes in female sexual activity. 
The total count of mounts, corresponding to LME + LOE + MOL also showed a 
significant decrease in the treated group, possibly as a result of reduced attraction by 
the female. Video recordings were taken during 30 minutes, and the following 
65 
 RESULTS   
parameters were analyzed on the video tapes: LH, LG, JW, MOL, LOE, LME (see 
chapter Materials and Methods).  
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Fig 38 Female sexual behavior: the behaviors observed are LH = female licking or sniffing head of male, LG = 
female licking or sniffing genitals of male, JW = jumping and wiggling (approaching behaviour of female 
towards male), MOL = mounting without lordosis, LME = lordosis with ejaculation, LOE = lordosis without 
ejaculation; (Mean +/- SD, n = 9 for both groups) (* = p < 0.01 in ANOVA test with pairwise comparison and 
Bonferroni correction) 
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Fig 39 The Lordosis Quotient (lordosis behaviours / total number of mounts) as an indicator for female 
perceptive behaviour (n = 9 for both groups) (* = p < 0.01 in ANOVA test with pairwise comparison and 
Bonferroni correction) 
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D. Estrogen target gene mRNA expression under steady state 
conditions (baseline) 
Results of the molecular biological analysis of adult F1 animals under steady state 
conditions are shown in this chapter. Females were studied in diestrus 1 (metestrus) 
which is characterized by low endogenous sex hormone levels. The test compounds 
were administered by s.c. injection to the pregnant dam from gestational day (GD) 10 
to 18. Because the compounds bioaccumulate the offspring are exposed from late 
embryonic life until adulthood, including the period of sexual brain differentiation 
(from GD18 to postnatal day 7). 
Ventromedial hypothalamic nucleus: mRNA expression in adult male and 
female F1 rat offspring - baseline series 
mRNA levels were determined in a tissue piece containing the ventromedial 
hypothalamic nucleus (VMH) by real time  RT PCR. 
Progesterone receptor mRNA in VMH 
Progesterone receptor (PR) mRNA exhibited a significant sex difference between 
males and females in the control group. The female PR mRNA level in the VMH is 
higher than in males. This sex difference was abolished in the treatment groups, both 
the PBDE99- and the PCB-groups, with the females showing a clear decrease of 
progesterone receptor mRNA. Male PR mRNA levels increased significantly in the 
low dose PBDE99 group (P1). In this treatment group, male and female levels were 
identical.  
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Fig. 40 Progesterone receptor (PR) mRNA level in ventromedial hypothalamus (VMH) of 
adult male and female F1 rat offspring. Mean ± S.D. (n=9). The level of progesterone 
receptor mRNA is normalized to cyclophilin mRNA (Cyc). Statistically significant 
differences of mRNA expression compared to control animals are indicated by * (p<0.05). 
† indicates a significant difference between control males and females (p<0.05). 
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Fig. 41 Progesterone receptor mRNA (PR) level in the ventromedial hypothalamus (VMH) 
of individual animals. PR mRNA level normalized to cyclophilin (Cyc). (n= 9 per group). 
 
Estrogen receptor alpha mRNA in VMH 
Both treatments, PBDE as well as PCB, lead to a significant increase of ER alpha 
mRNA level. The females appeared to be more affected than the males, where the 
increase was by far less considerable. 
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Fig. 42 Estrogen receptor alpha (ER alpha) mRNA level in the ventromedial hypothalamus 
(VMH) of adult male and female rat offspring. Mean ± S.D. (n=9) mRNA level of estrogen 
receptor alpha normalized to cyclophilin (Cyc) mRNA. Statistically significant differences 
of mRNA level compared to control are indicated by * (p<0.05) 
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Fig. 43 Estrogen receptor alpha (ER alpha) mRNA level in the ventromedial hypothalamus 
(VMH) of individual animals. PR mRNA level is normalized to cyclophilin (Cyc). (n= 9 
per group). 
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Estrogen receptor beta mRNA in VMH 
Shughruhe et al. (1997) have shown, that the estrogen receptor beta is not much 
expressed in the VMH. However, ER beta mRNA was detectable. Although the level 
was already very low in the controls, there was a significant decrease in the two 
PBDE99 groups in both sexes, whereas the PCB-mixture (Aroclor 1254) did not have 
a significant effect. 
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Fig. 44 Estrogen receptor beta (ER beta) mRNA level in the ventromedial hypothalamus 
(VMH) of adult male and female rat offspring. Mean ± S.D. (n=9) mRNA level of ER beta, 
normalized to cyclophilin (Cyc) mRNA. Statistically significant differences of mRNA level 
compared to control are indicated by * (p<0.05) 
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Fig. 45 Estrogen receptor beta (ER beta) mRNA level in the ventromedial hypothalamus 
(VMH) of individual animals. ER beta mRNA level is normalized to cyclophilin (Cyc). (n= 
9 per group). 
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Preproenkephalin mRNA in VMH 
The preproenkephalin mRNA level shows no difference between the sexes. This 
remains throughout all treatments. mRNA levels increase significantly in the PBDE 
groups and decrease in the PCB group. 
 
Preproenkephalin mRNA level in VMH
0
1
2
3
4
5
6
C
P1
P10
Aro10
* 
* 
* 
* 
1females 2males
Fig. 46 Preproenkephalin (PPE) mRNA expression in the ventromedial hypothalamus 
(VMH) of adult male and female F1 rat offspring. Mean ± S.D. (n=9) mRNA level of 
preproenkephalin normalized to cyclophilin (Cyc) mRNA. Statistically significant 
differences of mRNA level compared to controls are indicated by * (p<0.05). 
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Fig. 47 PPE mRNA level in the ventromedial hypothalamus (VMH) of individual animals. 
PPE mRNA level is normalized to cyclophilin (Cyc). (n= 9 per group). 
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Medial preoptic area: baseline mRNA expression in adult male and female F1 
offspring 
This chapter describes the results of the molecular biological analysis in the medial 
preoptic area (MPO) for the adult F1 generation under steady state conditions 
(baseline). 
Progesterone receptor mRNA in MPO 
The mRNA level of the progesterone receptor in the MPO shows no significant 
difference between males and females in the control group, and the treatment with 
either PBDE or PCB does not change this significantly. 
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Fig. 48 Progesterone receptor (PR) mRNA expression in the medial preoptic area (MPO) of 
adult male and female F1 rat offspring. Mean ± S.D. (n=9) mRNA level of the progesterone 
receptor normalized to cyclophilin (Cyc) mRNA. Statistically significant differences of the 
mRNA expression compared to controls are indicated by * (p<0.05). 
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PR mRNA level in MPO of individual rats
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Fig. 49 PR mRNA level in the MPO of individual animals. PR mRNA level is normalized 
to cyclophilin (Cyc). (n= 9 per group).  
 
Estrogen receptor alpha mRNA in MPO 
In the control animals there is no sex difference detectable in the mRNA level of 
estrogen receptor alpha in the MPO. This remains throughout all treatment groups. 
The P10 group exhibited a dramatic and significant increase of ER alpha mRNA. P1 
values tended to decrease, but this change was not significant. The PCB mixture was 
ineffective. Males and females of this treatment group showed different amounts of 
this gene’s mRNA, however, this difference is not significant due to the high standard 
deviation. 
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Fig. 50 Estrogen receptor alpha (ER alpha) mRNA expression in medial preoptic area 
(MPO) of male and female of adult F1 rat offspring. Mean ± S.D. (n=9) mRNA level of the 
estrogen receptor alpha normalized to cyclophilin (Cyc) mRNA. Statistically significant 
differences of the mRNA expression compared to controls are indicated by * (p<0.05). 
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Fig. 51 ERalpha mRNA level in the MPO of individual animals. ERa mRNA level is 
normalized to cyclophilin (Cyc). (n= 9 per group).  
 
Estrogen receptor beta mRNA in MPO 
PBDE treatment did not significantly change the mRNA level of estrogen receptor 
beta in the MPO in contrast to PCB treatment, which increased ER beta mRNA level 
considerably in females. 
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Fig. 52 Estrogen receptor beta (ER beta) mRNA expression in medial preoptic area (MPO) 
of male and female of adult F1 rat offspring. Mean ± S.D. (n=9) mRNA level of the 
estrogen receptor beta normalized to cyclophilin (Cyc) mRNA. Statistically significant 
differences of the mRNA expression compared to controls are indicated by * (p<0.05). 
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Fig. 53 ERbeta mRNA level in the MPO of individual animals. ERb mRNA level is 
normalized to cyclophilin (Cyc). (n= 9 per group).  
 
Preproenkephalin mRNA in MPO 
In the MPO of females as well as males the mRNA level of preproenkephalin 
decreased after both PBDE99 and PCB treatment. 
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Fig. 54 Preproenkephalin (PPE) mRNA expression in medial preoptic area (MPO) of male 
and female of adult F1 rat offspring. Mean ± S.D. (n=9) mRNA level of the PPE 
normalized to cyclophilin (Cyc) mRNA. Statistically significant differences of the mRNA 
expression compared to controls are indicated by * (p<0.05). 
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Fig. 55 PPE mRNA level in the MPO of individual animals. PPE mRNA level is 
normalized to cyclophilin (Cyc). (n= 9 per group).  
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E. Estrogen Challenge Experiments 
mRNA expression in VMH of adult gonadectomized male and female 
F1 rat offspring after a single dose of estradiol  
Possible changes in the sensitivity of genes for estrogen is another interesting 
endpoint for assessing the impact of endocrine disrupting chemicals during 
development. To further investigate this question, adult F1 offspring of both sexes 
were gonadectomized at 10 weeks of age in order to remove the internal production 
of sex steroids thus achieving a low, constant level. Two weeks later the animals 
were challenged with a single dose of estradiol, given by subcutaneous injection. 
mRNA levels of Progesterone Receptor (PR) and Preproenkephalin (PPE) were 
determined in VMH or MPO 6 hrs after the estradiol injection. 
 
PR mRNA in the ventromedial hypothalamus (VMH) after acute estrogen 
treatment 
Untreated control males exhibited a significant increase of PR mRNA level after 
treatment with estradiol, as compared to vehicle-injected controls. The same was true 
for animals prenatally treated with PBDE99 (10mg/kg/d). In contrast, the PBDE99 low 
dose group (1mg/kg/d) and the Aroclor1254 groups showed no induction of PR 
mRNA by estradiol. Differences between mRNA levels of vehicle-injected animals 
were observed for females treated with the PCB-mixture and for the males of both 
PBDE99 treated groups. 
In the VMH of females estradiol also caused a significant induction of PR mRNA. It 
appeared to be greater than in males. The sensitivity of PR to estradiol was dose-
dependently reduced by PBDE 99 with a significant reduction in the PBDE high dose 
group (P10), and in Aroclor-exposed offspring.  
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Fig. 56 Normalized mRNA level of progesterone receptor (PR) in the ventromedial 
hypothalamus (VMH) of adult gonadectomized F1 offspring injected with vehicle (n = 9) 
Mean values ±S.D. Significant differences between PBDE- or PCB-exposed groups and 
controls are indicated by * (p<0.05) 
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Fig. 57a Normalized mRNA level of progesterone receptor (PR) in the ventromedial 
hypothalamus (VMH) of gonadectomized females (n = 9) 6 hours after subcutaneous 
injection of one single dose of estradiol (E2) (10 µg/kg body weight) or vehicle (K). Mean 
values ±S.D. Significant differences between E2 and vehicle treated animals are indicated 
by * (p<0.05) 
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Induction of PR level in VMH 
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Fig. 57b Normalized mRNA level of progesterone receptor (PR) in the ventromedial 
hypothalamus (VMH) of gonadectomized males (n = 9) 6 hours after subcutaneous 
injection of one single dose of estradiol (E2) (10 µg/kg body weight) or vehicle (K). Mean 
values ±S.D. Significant differences between E2 and vehicle treated animals are indicated 
by * (p<0.05) 
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Fig. 57c Progesterone receptor (PR) mRNA levels in the ventromedial hypothalamus 
(VMH) of adult gonadectomized F1 offspring (n = 9) 6 hours after subcutaneous injection 
of one single dose of estradiol (E2) (10 µg/kg body weight) expressed as percentage of the 
corresponding vehicle-injected group of each chronic treatment group. Mean values ±S.D. 
Significant differences in mRNA induction by estradiol between PBDE- or PCB-exposed 
groups and untreated controls are indicated by * (p<0.05) 
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Fig. 58 Relative PR mRNA level in the VMH of individual gonadectomized rats 6 hours after subcutaneous 
injection of one single dose of estradiol (E2) (10 µg/kg body weight). The PR mRNA level is normalized to 
cyclophilin (Cyc). (n = 9 per group). 
 
PPE mRNA in VMH after acute estrogen treatment 
The mRNA level of PPE in the VMH of male offspring of untreated controls was not 
significantly affected by acute estradiol injection. The same was true for the PCB 
treated group (Aro10). Both PBDE99 groups showed a reduction of PPE mRNA by 
estradiol to about 50% of the control level. However, the PPE mRNA levels of vehicle 
controls was about 5fold higher in the 1mg/kg/d PBDE99 group as compared to the 
untreated control group, but similar to that of untreated controls in the 10mg/kg/d 
PBDE99 group. In the female VMH estradiol reduced the PPE mRNA level only in the 
10mg/kg/d PBDE99 group.  
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Fig. 59 Normalized mRNA level of preproenkephalin (PPE) in the ventromedial 
hypothalamus (VMH) of adult gonadectomized F1 offspring injected with vehicle (n = 9) 
Mean values ±S.D. Significant differences between PBDE- or PCB-exposed groups and 
controls are indicated by * (p<0.05) 
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Fig. 60 Preproenkephalin (PPE) mRNA levels in the ventromedial hypothalamus (VMH) of 
adult gonadectomized F1 offspring (n = 9) 6 hours after subcutaneous injection of one 
single dose of estradiol (E2) (10 µg/kg body weight) expressed as percentage of the 
corresponding vehicle-injected group of each chronic treatment group. Mean values ±S.D. 
Significant differences in mRNA induction by estradiol between PBDE- or PCB-exposed 
groups and untreated controls are indicated by * (p<0.05) 
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Fig. 61 Relative PPE mRNA level in the VMH of individual gonadectomized rats 6 hours after subcutaneous 
injection of one single dose of estradiol (E2) (10 µg/kg body weight). The PPE mRNA level is normalized to 
cyclophilin (Cyc). (n = 9 per group). 
 
mRNA expression in MPO of adult gonadectomized male and 
female rat offspring after acute estrogen challenge  
PR mRNA level in MPO after acute estrogen treatment 
Acute estradiol injection gives rise to a small but significant increase of progesterone 
receptor mRNA level in untreated male controls when compared to the corresponding 
vehicle group. After treatment with PBDE99 this effect is abolished with both groups 
(P1 and P10). Both PBDE99 treatments resulted in elevated PR mRNA levels in the 
vehicle control groups. In the PCB-treated group (Aro10) the effect of estradiol seems 
to be reversed, since the estradiol treated animals now show a significantly lower 
level of PR mRNA in the MPO than the vehicle treated ones. 
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The original 50% induction of PR mRNA by estradiol in the MPO of the control group 
was abolished in all treatment groups (PBDE and PCB). Only the control level seems 
to be different in these two groups: PBDE treatment did not affect the control level 
(vehicle controls), where PCB increased control levels. 
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Fig. 62 Normalized mRNA level of progesterone receptor (PR) in the medial preoptic area 
(MPO) of adult gonadectomized F1 offspring injected with vehicle (n = 9) Mean values 
±S.D. Significant differences between PBDE- or PCB-exposed groups and controls are 
indicated by * (p<0.05) 
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Fig. 63 Progesterone receptor (PR) mRNA levels in the medial preoptic area (MPO) of adult gonadectomized F1 
offspring (n = 9) 6 hours after subcutaneous injection of one single dose of estradiol (E2) (10 µg/kg body 
weight) expressed as percentage of the corresponding vehicle-injected group of each chronic treatment group. 
Mean values ±S.D. Significant differences in mRNA induction by estradiol between PBDE- or PCB-exposed 
groups and untreated controls are indicated by * (p<0.05) 
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Fig. 64 Relative PR mRNA level in the MPO of individual gonadectomized rats 6 hours after subcutaneous 
injection of one single dose of estradiol (E2) (10 µg/kg body weight). The PR mRNA level is normalized to 
cyclophilin (Cyc). (n = 9 per group). 
 
PPE mRNA in MPO after acute estrogen treatment 
Estradiol treatment of gonadectomized F1 males leads to a significant decrease of 
PPE mRNA level in the MPO of the control group. This effect is not altered after 
treatment with a low dose of PBDE99 (P1), but the higher dose (10mg/kg) abolished 
the repressive effect of estradiol. PCBs similarly abolished the repression of PPE 
mRNA by estradiol. PPE mRNA levels in vehicle-injected males exposed to PBDE99 
or PCB were lower than those of vehicle injected controls. 
Estradiol treatment tended to reduce PPE mRNA levels in the MPO of female 
controls and 1mg/kg PBDE99-exposed animals, but the effect was not significant. In 
the P10 and Aro10 groups, estradiol was ineffective. PPE mRNA levels of vehicle-
injected groups did not differ significantly from each other. 
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Fig. 65 Normalized mRNA level of preproenkephalin (PPE) in the medial preoptic area 
(MPO) of adult gonadectomized F1 offspring injected with vehicle (n = 9) Mean values 
±S.D. Significant differences between PBDE- or PCB-exposed groups and controls are 
indicated by * (p<0.05) 
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Fig. 66 Preproenkephalin (PPE) mRNA levels in the medial preoptic area (MPO) of one single dose of estradiol 
(E2) (10 µg/kg body weight) expressed as percentage of the corresponding vehicle-injected group of each 
chronic treatment group. Mean values ±S.D. Significant differences in mRNA induction by estradiol between 
PBDE- or PCB-exposed groups and untreated controls are indicated by * (p<0.05) 
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Fig. 67 Relative PPE mRNA level in the MPO of individual gonadectomized rats 6 hours after subcutaneous 
injection of one single dose of estradiol (E2) (10 µg/kg body weight). The PPE mRNA level is normalized to 
cyclophilin (Cyc). (n = 9 per group). 
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Synopsis of molecular results of estrogen target gene mRNA 
expression under steady state conditions (baseline) 
The final two tables are meant to give an overview of the results of the mRNA levels 
in estrogen target genes in adult rat offspring under steady state conditions (table 8) 
and for the estrogene challenge experiment (table 9), respectively. Shown are 
significant increase (↑) or decrease (↓) of mRNA levels of the examined genes as 
compared to the respective control group. 
It illustrates, that developmental exposure to either PBDEs or PCBs alter the 
regulation of mRNA levels in both brain regions of both sexes. The mode of action, 
however differs between PBDEs and PCBs. 
sex treatment 
group 
MPO VMH 
P1 - - - - ↑ ↓ ↑ ↓ 
P10 ↑ - ↓ - ↑ ↓ - ↓ 
 
 
 
females 
Aro10 - ↑ ↓ - - - ↓ ↓ 
P1 - - ↓ - ↑ - ↑ ↑ 
P10 ↑ - ↓ - - ↓ - - 
 
 
 
males 
Aro10 - ↑ - - - - ↓ - 
genes ER 
alpha 
ER 
beta 
PPE PR ER 
alpha 
ER 
beta 
PPE PR 
 
Tab. 8 Synopsis of mRNA levels in adult offspring after prenatal treatment with PBDE99 or a PCB-
mixture (Aroclor1254): ↑ = increase, ↓ = decrease, - = no change as compared to respective controls 
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PR PPE  
C P1 P10 Aro10 C P1 P10 Aro10
MPO ↑ ↓ ↑ ↓ ↓ ↓ - ↓  
females 
VMH ↑ ↑ ↑ ↑ ↓ ↓ ↓ ↓ 
MPO ↑ ↑ ↑ ↓ ↓ ↓ ↑ ↓  
males 
VMH ↑ ↑ ↑ ↑ ↓ ↓ ↓ ↑ 
Tab. 9 Synopsis of progesterone receptor and preproenkephalin mRNA levels in response to acute 
estradiol injection in the different prenatal treated groups of adult gonadectomized F1 rat offspring. 
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DISCUSSION 
In contrast to the rather well known effects of PCB on the developing nervous system 
very little is known about the effects of the structurally related PBDE. Despite the 
finding of very little effect in in-vitro systems (Meerts et al., 2001) the study at hand 
reveals some major effects of PBDE99 on brain development. It appears that the 
genetic program in sexually dimorphic brain regions of the rat is severely altered. 
This is a matter of concern as these regions are involved in the regulation of 
reproductive behavior (Gorski, 1980). As PBDE99 is one of the regularly detected 
brominated flame retardants in environmental samples, it has been selected for this 
study. The developmental toxicity of PBDE99 was evaluated with special regard to 
conventional as well as molecular toxicity parameters. As a comparative compound, 
the industrial PCB-mixture Aroclor1254 was added to this study. PCB are known to 
interfere with sexual brain differentiation (Hany et al., 1999). 
The study revealed that PBDE99 can interfere with sexual brain differentiation 
processes at the molecular and functional level. 
 
General toxicological parameters 
Litter size and survival rate 
With the exception of the high dose PCB group (30mg/kg Aroclor, Aro30) litter size 
and survival rate were not affected. This indicates that only this one dose showed 
unspecific toxic effects. Therefore the 30mg/kg Aroclor dosage group was eliminated 
in the subsequent molecular biology studies. 
 
Body and organ weights 
Body weights as well did not differ among the various treatment groups, again with 
the exception of the Aro30 group, with female bodyweights significantly lower than 
those of their age mates in controls and other treatment groups. Also, some females 
of the Aro30 group died at an age as early as around 1 month, and examinations 
post mortem pointed to the possibility that they may have suffered from waisting 
syndrome (data not shown). 
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As to organ weights the effect pattern differs between PCB treated animals and those 
treated with PBDE. The peripheral organs such as prostate and uterus are part of my 
colleague Raffaella Ceccatelli´s doctoral thesis (for further information see Ceccatelli, 
R. 2004).  
With the exception of the Aro30 group these findings in summary revealed no 
unspecific toxicological effects at the levels chosen for this study. 
 
Sexual development 
Anogenital distance 
Neither of the treatments showed any significant effect on the anogenital distance. 
 
Onset of puberty 
The onset of puberty, however, has been shifted in both sexes after treatment with 
the test compounds. Therefore it can be deduced that treatment has certain effects 
on sexual development. 
 
Effects on gene expression 
The present study revealed that pre- and postnatal exposure to either PBDE 99 or 
the PCB-mixture Aroclor 1254 results in long lasting changes in gene expression 
patterns of various estrogen-regulated genes (PR, ER alpha and beta and PPE) in 
sexually dimorphic brain regions of adult rat offspring. The data in females refer to 
diestrus day1 (metestrus). 
 
Steady state conditions (baseline) 
The first part of the examination of mRNA levels of estrogen-regulated genes in 
sexually dimorphic brain regions was done under steady state conditions (the so 
called baseline-experiment), which means that apart from the prenatal treatment with 
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pre- and postnatal exposure the animals underwent no further manipulation. 
Chemical analyses of adipose tissue in adult offspring showed that the animals were 
exposed also during postnatal ontogeny, as a result of the persistence of PBDE99 
(unpublished observations) and PCB (Hany et al., 1999). A comparison with tissue 
levels for humans (She et al., 2002; Schecter et al., 2003; Sjödin et al., 2003) and 
marine mammals (She et al., 2002) showed the tissue levels of the lower dose 
PBDE99 group to come close to the upper concentration range of PBDEs in these 
reported natural samples.  
Estrogen receptor alpha and beta mRNA expression in VMH and MPO of 
developmentally exposed adult offspring 
The ER alpha mRNA levels in the VMH region of adult rat offspring in the control 
group were found to be sexually dimorphic with males (with the exception of two 
possible outliers) showing lower levels than females. This finding is in line with what 
has been reported by Shughrue and coworkers (1992). Sexual differences in 
estrogen receptor concentrations in specific brain regions are well known and have 
been reported first by Rainbow and coworkers (1982). They were able to detect 
higher binding levels of tritium-labeled estradiol in extracts of cytoplasm from micro-
dissected female rat brain. The sexual difference may originate from the 
aromatization of testosterone during early postnatal life, when estradiol, derived from 
testosterone via aromatization by the enzyme aromatase, suppresses the expression 
of estrogen receptors. Aromatase mRNA levels in the brain are higher in early 
postnatal stages than in adulthood, and moreover, they are higher in certain forebrain 
regions of males as compared to their female counterparts (von Ziegler et al., 1991; 
Lauber and Lichtensteiger, 1994; Lauber et al., 1997). 
Treatment with PBDE 99 as well as with the PCB-mixture led to an increase of ER 
alpha mRNA level in the VMH of both sexes. However, the relative sex difference 
persisted in all treatment groups despite the actual change in the absolute level of 
mRNA. In the MPO treatment with the high dose of PBDE99 affected ER alpha in a 
similar way as in VMH (up-regulation). The low dose of PBDE99 and Aroclor were 
ineffective. In contrast to Brown and co-workers (1988) we did not observe a 
significant sex difference in nuclear estrogen receptors.  
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Following acute exposure to estradiol Lauber and co-workers (1990) found a down-
regulation of estrogen receptor sites in the ventromedial hypothalamic nucleus in 
female rats. The present data reflect the effect of long term exposure; whether they 
result from perinatal actions or from ongoing exposure, cannot be decided. PBDE99 
was found to exhibit weak estrogenic activity (Meerts et al., 2001). Actions in the 
adult brain would thus be expected to decrease rather than increase ER alpha levels. 
Thus, the increase observed in exposed offspring might result from a developmental 
action. 
ER beta mRNA levels were significantly reduced in VMH of both sexes by PBDE99, 
whereas the PCB mixture was ineffective. In MPO, in contrast the expression of this 
receptor was not affected by PBDE99, but up-regulated by Aroclor in females. This is 
one of the examples of qualitative differences in the effect patterns of the 
polybrominated diphenylether and polychlorinated biphenyl mixture. As in the case of 
ER alpha, it cannot be definitely decided whether the changes in gene expression 
resulted from early developmental or adult exposure. 
The action of estrogen on transcription in neuronal development and function is 
mediated via estrogen receptors. Nuclear estrogen receptors function as ligand-
modulated nuclear transcription factors, which regulate the expression of target 
genes, e. g. of sites in the genome encoding for neurotransmitters (Romano et al., 
1989). ER alpha has been discovered in the 1960s in the brain of females. It took as 
long as to the middle of the 1990s until the second member of the steroid receptor 
superfamily named ER beta, has been discovered, first in the prostate (Kuiper et al., 
1996) and later in brain tissue. The distribution patterns of these two estrogen 
receptors, ER alpha and ER beta, differ from brain region to brain region. ER alpha 
can be detected in distinct cell populations in the medial basal hypothalamus, 
including the VMH, as well as in the MPO of adult rats. ER beta is found in the MPO 
and other brain regions, levels in the VMH are low (Shughrue et al., 1997). It should 
be noted that particularly in central nervous system, estrogen receptors located in the 
cell membrane play a significant role (Minami et al., 1990; Abraham et al., 2003, 
2004; Wade and Dorsa, 2003). This is true also for developmental processes (Beyer 
and Karolczak, 2000). Model systems based on binding to nuclear receptors or 
transcriptional effects would not reveal activities at membrane receptors. This might 
possibly explain why we observed drastic changes induced by PBDE99 even if this 
compound displays very little, if any, estrogenic activity in vitro (Meerts et al., 2000). 
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However, it is also conceivable that PBDE99 may have acted via mechanisms not 
involving sex steroid signaling.  
Progesterone receptor mRNA expression in VMH and MPO of developmentally 
exposed adult offspring 
Progesterone receptor (PR) mRNA levels in the VMH of controls showed a significant 
sex difference with a higher PR mRNA level in females than in males. This is in line 
with earlier reports that expression of PR is region- and sex-specific (Brown et al., 
1987; Lauber et al. 1991). After treatment with either PBDE 99 or Aroclor1254, this 
sexual dimorphism disappeared. The effect was most clear-cut in the low dose PBDE 
group (P1), where the females´ level decreased and at the same time the level in 
males increased, yielding almost the same levels in both sexes. Female sexual 
behavior in rats depends directly on PR expression in VMH, as demonstrated by 
Ogawa and coworkers (1994), who observed an almost complete loss of the lordosis 
reaction of the female in response to mounting by a male, after local injection of 
antisense oligonucleotides against PR mRNA. The significant alteration in PR 
expression may be involved in the repression of female sex behavior observed in 
PBDE99-exposed offspring. 
In MPO, PR mRNA level showed no significant sex-differences in controls and 
prenatal treatment with PBDE 99 as well as with PCB had no effect on the PR mRNA 
expression in the MPO. This again illustrates the regional specificity of xenobiotics-
induced alterations in gene expression at brain level. 
Preproenkephalin mRNA expression in VMH and MPO of developmentally 
exposed adult offspring  
PPE is the precursor peptide of met-enkephalin and is expressed in the central 
nervous system at early developmental stages (Yamano et al., 1984; Watson et al., 
1988) and its expression has been shown to be regulated by steroid hormones 
(Priest et al., 1995). 
Expression of PPE, the precursor of the neuropeptide enkephalin, is also directly 
correlated with female sexual behavior. In VMH and MPO of control animals the level 
of PPE mRNA exhibited no sex difference, but marked changes were caused by the 
two treatments. PPE mRNA levels in male and female VMH almost doubled after 
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exposure to the lower PBDE99 dose, whereas the PCB mixture caused the opposite 
effect, a pronounced down-regulation. 
However, the contrasting effect of the two types of chemicals in one of the regions 
(VMH) and the regional differences indicate that the underlying mechanisms are 
complex also in the case of PPE. The marked difference between low and high 
PBDE dose in VMH is interesting. It might be part of a bell-shaped dose-response 
curve, but this could only be decided with an extended dose range. 
Acute estrogen challenge 
Developmental alterations of regulatory systems need not become manifest under 
steady state conditions, when certain deficits may be balanced. Also, steady state 
mRNA levels are difficult to interpret in chronic exposure situations. More direct 
informations on the functional state of the system can be expected from challenge 
experiments. 
A number of studies reported that in both of the examined sexually dimorphic brain 
regions, the expression of certain genes is regulated by estradiol in adult animals 
(MacLusky and McEwen, 1980; Romano et al., 1989, Lauber et al., 1991). For the 
assessment of PBDE99´s potential to harm this regulatory system in early stages of 
development, the sensitivity of target genes to acute injection of estradiol has been 
analyzed in adult rat offspring. In order to eliminate endogenous sex hormone 
production, the animals were gonadectomized two weeks prior to the experiments. 
The animals were given one single dose of estradiol or just the solvent as a control, 
and sacrificed six hours later for further analyses of the tissues. 
Sensitivity of PR mRNA expression in VMH and MPO of developmentally 
exposed adult offspring 
After administration of a single dose of estradiol PR mRNA was significantly induced 
in VMH and MPO of adult gonadectomized control animals as compared to the 
respective vehicle injection. Females seemed to be more sensitive than males by 
exhibiting a higher relative increase in PR mRNA than males. In former studies it has 
been shown that there is in fact a quantitative sex difference in the induction of PR 
mRNA by estrogens (Lauber et al., 1991). The observations on controls within the 
study at hand are also supported by earlier findings of higher levels of estrogen-
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inducible PR mRNA in specific nuclei of the female hypothalamus (Rainbow et al., 
1982; Brown et al., 1987 and 1990). As to the other examined region, the medial 
preoptic area (MPO), the present study did not show any sex difference in the 
reaction of PR mRNA levels to estradiol administration. Both control groups exhibited 
similar induction patterns of PR mRNA. This is in keeping with earlier findings of 
Brown and collaborators who in 1987 found no differences in the reaction pattern 
between the two sexes.  
The PR mRNA levels of vehicle-injected rats, which reflect the “baseline level” of 
gonadectomized offspring, exhibited small differences. These changes are difficult to 
interpret, since the molecular actions of PBDE99 are not yet well characterized, and 
Aroclor represents a mixture of PCB congeners. The slight increase observed in the 
majority of groups could possibly result from weak estrogenic actions (Meerts et al., 
2001).  
However, we are more interested in the magnitude of PR mRNA induction relative to 
the vehicle-injected level, since this parameter reflects the sensitivity to estrogen. 
Prenatal treatment with PBDE 99 or PCB changed the sensitivity of males severely. 
PR mRNA induction by estradiol was generally reduced in VMH as well as MPO of 
both sexes. The only exception is male VMH, which exhibited enhanced PR mRNA 
induction in the group exposed to the higher PBDE99 dose, but reduced induction in 
the lower dose PBDE99 group.  
Prenatal PBDE 99 as well as PCB exposure affected the sensitivity of PR expression 
to estradiol in a rather dramatic way. In male VMH and male and female MPO, the 
response to estradiol was virtually abolished, PR mRNA remained at 100% of the 
vehicle-injected group. As in the case of the data collected under steady state 
conditions, it cannot be definitely decided whether the changes in responsiveness to 
estradiol are the result of interactions with developmental mechanisms, or of actions 
of the chemicals still present in the adult offspring. If PBDE99 could be regarded as a 
weak partial agonist at ER, then the reduced induction of PR mRNA by estradiol 
might tentatively be explained by antagonistic actions. However, this would not 
explain the opposite effect – enhanced induction – in VMH of PBDE99 10mg/kg-
exposed males. Also, it should be noted that PCB have been shown to change key 
elements of endocrine regulation such as aromatase activity in neonatal brain (Hany 
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et al., 1999). Thus it appears that either test-compound had a high developmental 
impact on this delicately balanced regulatory system. 
The changes in sensitivity strengthen the findings of the baseline experiment of the 
present study where prenatal treatment with PBDE99 provoked changes in PR 
mRNA levels, leading to a loss of sexual dimorphism in the VMH. 
Sensitivity of PPE mRNA expression in VMH and MPO of developmentally 
exposed adult offspring 
As a second target gene to analyze influences of developmental exposure to 
PBDE99 on the sensitivity to estradiol, preproenkephalin (PPE) was chosen. Since a 
number of studies already have shown that PPE gene expression is inducible by 
administration of estrogens in hypothalamus and medial preoptic area of 
gonadectomized rats (Romano et al., 1988, 1990; Priest et al., 1995; Segarra et al., 
1998) PPE appeared to be a suitable target for this purpose. 
The situation in the study at hand is rather complex with regard to this particular 
gene. What strikes most is the huge inter-individual variability among all treatment 
groups. This led to very high standard deviations, rendering statistically solid 
statements difficult. In the VMH of female as well as male controls there was almost 
no effect of estradiol on the mRNA level of PPE detectable. In contrast, previous 
studies reported PPE mRNA expression to increase after estradiol administration 
(Romano et al., 1988, 1990; Zhu et al., 2001). However, the reaction of PPE mRNA 
synthesis seems to be very complex, as Priest and co-workers (1995) found that in 
ovarectomized Long-Evans rats, treatment with estradiol leads to a multiphasic 
change in PPE mRNA level over the course of 48 hours, with an early peak followed 
by a decrease at around 4 hours and a late increase. It is difficult to asses to which 
time point of Priest´s study corresponds the time point of 6 hours chosen in the 
present study. 
However, it appears that the animals were investigated during the secondary phase 
of decreasing PPE mRNA levels, since in untreated controls PPE mRNA was 
reduced by estradiol to 50-80% of the level of vehicle-injected rats in VMH. 
Developmental PBDE99 exposure further enhanced the repressive effect of estradiol 
in VMH, whereas the PCB mixture reduced the estradiol effect. 
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In a study carried out by Lauber and collaborators (1990) the administration of 
estradiol to ovarectomized female rats via incorporated capsules had no effect on 
PPE mRNA in the MPO. In line with that is the finding of this study with no significant 
effect of estradiol injection on the PPE mRNA level in MPO. Also prenatal treatment 
with PBDE99 or PCB had no effect in this region in females. 
In the MPO of control males treatment with estradiol caused a significant suppression 
of PPE mRNA. This suppressive effect remained unchanged after prenatal treatment 
with the low dose of PBDE99 (P1-group), whereas in the high dose group of PBDE99 
(P10-group) as well as the PCB treated group (Aro10), the effect of estradiol was 
blunted (Aro10) or even reversed (P10). 
Taken together, those findings demonstrate that developmental exposure to PBDE 
99 and PCB is able to influence PPE mRNA expression under steady state 
conditions as well as the response to acute estrogen administration, in a sex- and 
region-specific manner. The contrasting differences in the effect of PBDE99 on 
estradiol-induced changes in PR mRNA and PPE mRNA expression (reduced versus 
enhanced sensitivity) and the region- and sex-specific differences appear to speak in 
favor of changes resulting from developmental actions. In particular the combination 
of reduction of responsiveness to estradiol in one gene and enhanced 
responsiveness in another gene would be difficult to explain by a simple mechanism 
such as partial agonist of persisting PBDE99. 
Whether the effects on PPE have any consequences on functional levels other than 
mRNA or whether other physiological or behavioral endpoints are affected, is not 
known. Lauber and coworkers (1990) have been able to show that an estrogen 
induced increase of PPE mRNA levels in the VMH correlates directly with the 
induction of lordosis behavior in a dose dependent manner. Also mRNA levels of 
PPE are directly correlated with the female estrous cycle (Funabashi et al. 1995). In 
addition it was demonstrated that blockage of PPE expression by injection of 
antisense oligos for PPE mRNA into the hypothalamus results in a rather dramatic 
repression of female lordosis behavior (Nicot et al., 1997), similar to the effect of PR 
mRNA antisense oligos. 
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Adult Reproductive Functions 
Estrous cycle 
The female estrous cycle was severely affected by both treatments, PCB as well as 
PBDE99 in all treatment groups. Cycles were studied continuously by taking vaginal 
smears over a period of about two to three weeks. The alterations of the estrous 
cycle in the treated females suggest actions of an endocrine disrupter. 
Sexual behaviour 
According to Zipse (2000) the proceptive behavior of female rats can be altered after 
animals have been treated with sex hormones. In line with this is the finding of this 
study with the drop down of jumping and wiggling behavior in the PBDE99-treated 
group as compared to the control group. This may have been caused by the potential 
action of PBDE99 as an endocrine disrupter. 
It seems plausible that with the PBDE99-exposed females showing less proceptive 
behavior and thus the male being less attracted, the number of mounts is significantly 
decreasing. In addition, we observed a dramatic decrease of the lordosis quotient, 
which represents the quotient of the total numbers of lordosis divided by the total 
numbers of mounts. This indicates that female sexual behavior of PBDE99-exposed 
offspring was also impaired, besides the alteration of proceptive behavior. What 
could not be clarified within this study is the mechanism underlying the disturbed 
female sexual behavior. It might have been linked in part to the irregular estrous 
cycle. Both phenomena may have been caused by alterations at brain level as 
indicated by our molecular biology data. Since female sexual behavior depends on 
the estrous cycle, females were always taken in proestrous/estrus for the behavioral 
experiments. However, due to their disturbed estrous cycle it was not easy to 
determine the exact estrous cycle state of the PBDE99-treated females. Therefore 
altered behavior in the experiment may just reflect the changed estrous cycle after 
treatment with PBDE99. 
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Conclusions 
Possible interactions of environmental chemicals with the neuro-endocrine system 
are a matter of serious concern. Being involved in reproduction, impaired function 
might threaten fitness and survival of species. Yet, so far the impact of endocrine 
active environmental chemicals on the control of central neuroendocrine processes 
has not earned as much interest in research as its possible consequences urgently 
would suggest. Instead the focus has been mainly on reproductive organs. Merely 
organochlorine pesticides and PCBs have been shown to interfere with processes of 
sexual brain differentiation (vom Saal et al., 1995; Hany et al., 1999). Alterations in 
gene expression patterns following developmental exposure to a chemical UV-filter, 
4-methylbenzylidene camphor (4-MBC), have recently been examined in sexually 
dimorphic brain regions as well as in reproductive organs (Maerkel et al., 2005). 
The present study could show that developmental exposure to PBDE 99, an 
endocrine active flame retardant present in many environmental samples (Zennegg 
et al., 2002), can affect processes of sexual brain differentiation on molecular 
integration levels. These effects were manifest in a range of PBDE 99 dosages that 
did not show any signs of general toxicity, as indicated by the absence of effects on 
survival rate and body weight. 
However, the significance of changes in mRNA levels following developmental 
exposure to PBDE is difficult to asses in terms of possible consequences on higher 
integration levels. More information on the functional state of regulatory 
neuroendocrine systems was obtained from the estrogen challenge experiment. It 
was designed to assess the efficiency of transcriptional effects of estrogens (i. e. 
estradiol) on the induction or repression of target genes. The data obtained suggest 
severe changes in the sensitivity of genes involved in neuroendocrine control to 
natural estrogens. 
However, the changes at the molecular level might as well reflect processes of 
adaptation to newly arising environmental conditions and a new chemical milieu 
under which the organisms have to develop. The assessment of a possible actual 
threat to species preservation has to be carried out at higher biological integration 
levels. The behavioral study performed in this project was intended to provide first 
insight into that matter. 
As already mentioned, the data on PR mRNA expression in VMH suggested possible 
effects on female sexual behavior, induction of progesterone receptor in VMH by 
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estrogen is central to the induction of female sexual behavior. The massive reduction 
of the lordosis reaction (lordosis quotient) in females exposed to the higher dose of 
PBDE99 (the only dose tested), may have been linked with the reduction of 
progesterone receptor gene expression in the VMH. 
The alterations in estrogen target gene regulation at brain level may also have played 
a role in the severely altered estrous cycle. This may in turn have influenced 
behavior. It turned out to be very difficult in the PBDE-treated group to determine the 
actual cycle state, because the vaginal smears showed different cell types at one 
time. It was necessary for this group to follow the cycle for some time and then select 
a state that in terms of the proportion of cell-types came closest to the state required 
for the behavioral experiment (i. e. proestrous/estrous). Alterations in estrous cycle 
and sexual behavior probably result both, at least in part from a disturbed 
differentiation of the CNS during early stages of development. 
The present study illustrates that, in addition to classical toxicological parameters, the 
analysis of gene expression can be considered as a novel approach to study effects 
of endocrine active chemicals on brain differentiation. 
Outlook 
In order to asses the practical threat of endocrine disrupting chemicals such as 
PBDE99 to the biological fitness of animals, it would be interesting to find out more 
about the impact on reproduction. Therefore further experiments would be useful 
which show, whether developmentally exposed F1 females would actually get 
pregnant and if their maternal behavior is affected in a way that would make them 
incapable of raising offspring. 
 
“Save the best for last” 
From October 2004 on penta- and octa-bromodiphenyl ether are prohibited in the 
European Union (directive 2003/11/EC, published in the “Official Journal of the 
European Union”, February, 15th 2003). “In order to protect health and the 
environment the placing on the market and the use of pentaBDE and octaBDE and 
the placing on the market of articles containing one or both of these substances 
should be prohibited.” 
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ABBREVIATIONS 
 
Aro: Aroclor 1254 
 
BDE: brominated diphenyl ethers 
 
ERα: Estrogen Receptor α 
 
ERβ: Estrogen Receptor β 
 
GD: gestational day 
 
MPO: medial preoptic region 
 
PR: Progesteron Receptor 
 
PBDEs: polybrominated diphenyl ethers 
 
PBDE47: 2,2’,4,4’-tetrabromodiphenyl ether 
 
PBDE99: 2,2’,4,4’,5-pentabromodiphenyl ether 
 
PN: postnatal day 
 
PPE: preproenkephalin 
 
P1: PBDE 99 1mg/kg 
 
P10: PBDE 99 10mg/kg 
 
VMH: ventromedial hypothalamus 
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